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ABSTRACT
Cellular adhesion to the extracellular environment is a critical component of
physiological processes and its dysregulation drives pathological processes such as cancer
metastasis. The input cells derive from their interaction with the extracellular matrix
(ECM) is largely mediated through specialized organelles known as focal adhesions (FAs).
FAs tether extracellular matrix-bound integrins to the contractile actin cytoskeleton and
serve as attachment points which allow the cell to exert force on the extracellular
environment via acto-myosin contractility. In addition to this structural role, FAs function
as dynamic signaling hubs that respond to changes in force. Reversible phosphorylation
plays a major role in relaying these mechanical signals. While tyrosine phosphorylation
within this context is well studied, serine and threonine phosphorylation, despite being
more abundant within FAs, are comparatively less well characterized and understood. Our
lab has evidence indicating that protein kinase A (PKA), a patriarchal serine/threonine
kinase which is involved in mechanically regulated signaling in other subcellular
compartments, may also be active within FAs.
To investigate this possibility, we used immunofluorescence and live cell imaging
approaches to characterize changes in FA morphology and cellular traction force upon
treatment of cells with a specific inhibitor of PKA. PKA inhibition increased FA size and
aspect ratio and increased traction force in spreading cells. Subsequent studies suggested
these changes might be a consequence of reduced phosphorylation of RhoA by PKA. We
utilized microtubule depolymerization and regrowth as a tool to discretely study changes
in adhesion dynamics and found that PKA inhibition prevented FA disassembly during
microtubule regrowth. However, it is unknown whether any of these changes were due to
the activity of PKA within adhesions themselves or elsewhere in the cell. Since global
inhibition of PKA makes it impossible to target PKA activity only within adhesions, we
provide preliminary evidence of the utility of the optogenetic tool OLAF (Optogenetic
Localization of A kinase to Focal Adhesions) in this endeavor. OLAF allows for discrete
and reversible recruitment of active PKA to FAs and will be an invaluable tool in
understanding how PKA activity contributes to FA dynamics. The work presented here
shows a role for PKA in controlling FA dynamics and traction force and provides a
preliminary investigation of an optogenetic method to specifically study the role of PKA
activity within FAs.
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CHAPTER 1: Literature Review
1.1. Cell Adhesion
1.1.1 Introduction to Cell Adhesion
Cells physically connect to and derive mechanical information from the
extracellular environment in a process known as cell adhesion. This interaction is vital to
embryonic development and the maintenance of tissue homeostasis throughout life. Most
mammalian cells exhibit anchorage-dependent growth, whereby their survival,
proliferation, and differentiation depend heavily on their physical connection to and
interaction with the extracellular matrix (ECM) (Walker, Fournier, & Assoian, 2005). It is
becoming increasingly evident that dysfunctional cell adhesion and the pathways that
govern this process contribute to and may be causative factors in the etiology of major
pathologies such as cardiovascular disease and cancer (Hahn & Schwartz, 2009; Paszek et
al., 2005). Importantly, dynamic regulation of cell adhesion is necessary for both cell
spreading, as cells flatten and adhere to their substrate, and directional cell migration.
Under tight control in physiological states, these processes are indispensable for wound
healing, embryogenesis, and the immune response. However, when this tight control is
disrupted, it can lead to disease processes such as cancer metastasis.
1.1.2 Extracellular Matrix (ECM)
Rather than serving as inert scaffolding for tissues as originally conceptualized, the
ECM provides important chemical and mechanical input to the cell that affects cellular
processes such as growth, proliferation and migration (Rozario & Desimone, 2010; Singh,
Carraher, & Schwarzbauer, 2010). The ECM consists of a heterogenous network of fibrous
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proteins such as collagen and fibronectin, embedded within a proteoglycan hydrogel
(Frantz, Stewart, & Weaver, 2010). These fibrous proteins give the ECM structure and
tensile strength. They also interact directly with cell surface membrane receptors to
facilitate adhesion (Harburger & Calderwood, 2009). Importantly, the structure of the ECM
is highly dynamic and subject to remodeling. Changes in ECM protein concentration,
crosslinking and post translational modifications can alter the rigidity of the extracellular
environment. For example, matrix metalloproteases (MMPs) degrade ECM while lysyl
oxidase (LOX) enzymes crosslink and stiffen it (Kagan & Li, 2003; Page-McCaw, Ewald,
& Werb, 2007). ECM rigidity varies across the spectra of tissue within the body, exerting
influence over tissue homeostasis and contributing to the progression of disease states.
1.1.3 Mechanobiology (a primer)
While soluble and embedded ligands within the ECM provide important chemical
information to the cell, variations in ECM rigidity and the resulting variation in applied
force to the cell can have profound impacts on cellular behavior. Cells derive important
mechanical information about their surroundings from the ECM and their function is highly
tuned to the mechanical input specific to their physiological niche. Furthermore, most cells
exert reciprocal force on their environment, existing in a tensional homeostasis between
cytoskeletal generated cellular tension and extracellular forces (Webster, Ng, & Fletcher,
2014). While the mechanisms behind this mechanical reciprocity will be discussed later, it
is important to understand the extent to which mechanical force can impact physiological
and pathological processes.
Within the body, cells are exposed to a variety of extracellular forces including
shear, compressive and tensile stresses (Butcher, Alliston, & Weaver, 2009). For example,
2

endothelial cells lining the vasculature are constantly subject to shear fluid stress from
blood flow (Hahn & Schwartz, 2009). Transient and sustained increases in blood pressure
result in circumferential stretching of endothelial cells and the smooth muscle cells that
surround them (Hahn & Schwartz, 2009). Bone maintenance, including both bone
formation and resorption depend heavily on mechanical input (Huiskes, Rulmerman, Van
Lenthe, & Janssen, 2000). Matrix stiffness also plays a particularly important role in
embryonic development and mesenchymal stem cells undergo lineage selection based on
matrix rigidity (Huebsch et al., 2010; Rozario & Desimone, 2010). For example, soft
matrices within the brain promote neurogenic lineages while stiffer matrices like those in
muscle and bone result in myogenic and osteogenic lineages (Engler, Sen, Sweeney, &
Discher, 2006).
Since force plays such an important role in tissue homeostasis, it is not surprising
that alterations in force input and force sensitive cellular machinery are hallmarks of
disease states such as cardiovascular disease and cancer. Disturbances in normal blood
flow and pressure that result from plaque buildup in arteries alter adhesion molecule
expression and contribute to the pathogenesis of atherosclerosis (Chappell, Varner, Nerem,
Medford, & Alexander, 1998; Hahn & Schwartz, 2009). The importance of
mechanobiology has been particularly well-appreciated within the field of cancer research.
Tumors are often characteristically stiffer and have more rigid desmoplastic stroma than
surrounding tissue (Butcher et al., 2009; Paszek et al., 2005). In fact, palpation is often
used as preliminary screening method to identify tumors, with increasing stiffness
indicative of a poorer prognosis (Colpaert, Vermeulen, Van Marck, & Dirix, 2001). ECM
remodeling proteins such as MMPs and LOX enzymes are frequently upregulated in
3

cancer, resulting in abnormal matrix rigidity (Alex, 2006; Pucci et al., 2019; Wei et al.,
2017). Transformed cells often show anchorage independence with a decreased reliance on
adherence to a substrate for their metabolism and proliferation (Wittelsberger, Kleene, &
Penman, 1981). Further, they often have atypical mechano-reciprocity and are capable of
exerting abnormally high force on their environment, disrupting normal cell adhesion and
promoting an invasive phenotype (Butcher et al., 2009). Indeed, genetic/proteomic screens
have shown abnormal expression of adhesion proteins in malignant cells, likely
contributing to aberrations in rigidity sensing and response (Cance et al., 2000; Canel,
Serrels, Frame, & Brunton, 2013; Levental et al., 2009; Mitra & Schlaepfer, 2006).
Thus, understanding how cells interpret and respond to mechanical cues in their
environment is critical to the development of novel therapies that exploit differences in
mechanobiology between physiological and pathological disease states.
1.1.4 Cytoskeleton
In order to sense and respond to force, cells have machinery that allows them to
bear and generate forces themselves. This is accomplished mainly through the
cytoskeleton, the dynamic architecture that spatially organizes the cell, gives it mechanical
strength and structure, generates forces, and connects the cell to the external environment
via integrins and focal adhesions (FAs). The cytoskeleton is made up of 3 families: actin,
microtubules and intermediate filaments. Of these, the actin cytoskeleton has classically
been the focus of discussion related to cell migration and adhesion. However, the role of
microtubules in regulation of adhesion machinery has been increasingly well appreciated
and will be discussed briefly (Seetharaman & Etienne-Manneville, 2019).
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1.1.4.1 Microtubules
Microtubules are hollow structures made up of polymerized a and b tubulin
heterodimers which play an important role in intracellular transport, cell division, and
establishment of cell polarity. These highly dynamic structures are polarized, with a “minus
end” which is stabilized at microtubule organizing centers in the cell, and fast growing
“plus ends” which grow towards the periphery of the cell (Akhmanova & Steinmetz, 2015).
Their growth and instability are regulated by microtubule associated proteins such as plus
end and minus end tracking proteins, and motor proteins such as kinesins and dyneins.
These proteins interact with microtubules and other proteins to regulate microtubule
polymerization and depolymerization as well as allowing microtubules to serve as
highways for vesicular transport within the cell. Of particular relevance to this project,
microtubules also interact with regulatory and structural components of the cellular
adhesive machinery such as regulators of Rho family GTPases, adhesion proteins and the
actin cytoskeleton (Seetharaman & Etienne-Manneville, 2019).
1.1.4.2 Actin Cytoskeleton
The actin cytoskeleton is the primary structure in the cell responsible for
determining and altering cell shape. It does so by bearing and helping (in collaboration
with myosin) to generate force; as such, it plays a particularly important role in
mechanically sensitive signaling within the cell. Actin realizes this importance through
three major characteristics: polymerization, acting as a scaffold for molecular motors of
the myosin family, and attachment to ECM anchor points.
The actin cytoskeleton is made up of monomeric globular actin (G-actin) subunits
which polymerize to form filamentous actin (F-actin) (Pollard, 2016). F-actin
5

polymerization proceeds in a polarized manner, with elongation occurring faster at the
“barbed” end of the filament than at the “pointed” end (Pollard, 2016; Woodrum, Rich, &
Pollard, 1975). The organization and growth of actin filaments is regulated by a family of
proteins known as actin binding proteins (ABPs), which coordinate aspects of actin
assembly. ABPs are responsible for maintaining a pool of actin monomers, nucleating
assembly of new filaments, promoting and terminating elongation, and cross-linking
filaments.
The ability to fine tune actin polymerization and depolymerization via different
ABPs allows for the formation of distinct actin structures in the cell that contribute to
different aspects of cell movement (Pollard, 2016). For example, specific ABPs help to
form filopodia, finger like protrusions formed at the leading edge of cells that explore and
sense the local environment. Bundling and crosslinking of actin filaments gives filopodia
the strength and structure to resist buckling under force (Svitkina, 2018). The lamellipodia,
on the other hand, is a branched network of actin filaments responsible for generating
forces to propel the leading edge of the cell forward. The activity of other ABPs such as
Arp2/3 and the WAVE regulatory complex create this unique dendritic structure that is
strong enough to push against the plasma membrane and produce a forward propulsive
force (Blancholn et al., 2000).
One of the most important roles of the actin cytoskeleton is the generation of
contractile force. This occurs through the activity of a third actin structure—stress fibers,
which are bundles of antiparallel actin and myosin-II which span the cell and are anchored
on either end by FAs (Svitkina, 2018). Actin filaments in stress fibers are stabilized and
crosslinked into bundles which associate with molecular motors of the myosin II family
6

(Burridge & Wittchen, 2013). Myosin-IIs bind and move along actin via ATP hydrolysis
to pull actin filaments together and generate force (Shutova & Svitkina, 2018). Stress fibers
are effectively bound to the ECM via FAs and integrin complexes (discussed in detail
below) and are prominent in cells exposed to high forces (Burridge & Wittchen, 2013).
This critical connection transmits the forces generated by contractile stress fibers (which
would otherwise collapse the cell) to the underlying substrate, a phenomenon known as
cellular traction force.
1.1.4.3 Cytoskeletal Regulation by Rho Family GTPases
To respond to force and maintain tensional homeostasis with the extracellular
environment, cells exert dynamic control over their cytoskeletal machinery. While many
signaling proteins contribute to cytoskeletal regulation, Rho family small guanosine
triphosphate (GTP) binding proteins (GTPases) have emerged as master regulators of this
mechanosensitive machinery (Bishop & Hall, 2000; Nobes & Hall, 1995). They play an
important role in the coordination of migratory signaling pathways and their activity is
indispensable for cell migration (Raftopoulou & Hall, 2004).
The Rho family GTPases, including the canonical members RhoA, Rac and Cdc42,
are encompassed within the Ras small GTPase superfamily and regulate important cellular
functions such as cell spreading, adhesion and migration (Lawson & Burridge, 2014).
These ubiquitously expressed enzymes hydrolyze the gamma phosphate from GTP and
exist in both active (GTP-bound) and inactive (GDP-bound) states which are modulated
through the activity of guanine exchange factors (GEFs) and GTPase activating proteins
(GAPs). GEFs exchange GDP for GTP to activate GTPases while GAPs catalyze intrinsic
GTPase activity to turn off their activity. Another family of regulatory proteins, guanine
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nucleotide dissociation inhibitors (GDIs), bind the inactive GTPase, sequester it to the
cytosol and prevent activation. The combined activity of GEFs, GAPs and GDIs confer a
high degree of spatiotemporal control over the activity of these proteins and greatly
influence the coordination and synchronization of their activity required for cell migration
(Raftopoulou & Hall, 2004).
While the activity of all three canonical members of the Rho GTPase family is
required for cell migration, they each play distinct roles. Rac and Cdc42 regulate actin
polymerization to promote lamellipodial and filopodial protrusion at the leading edge of
cells (Nobes & Hall, 1995). As will be discussed later, Rac-induced actin polymerization
plays an important role in focal complex formation (Choi et al., 2008; Nobes & Hall, 1995).
Given these roles, Rac and Cdc42 are active primarily at the leading edge of migrating cells
(Raftopoulou & Hall, 2004). On the other hand, RhoA is active both at the leading edge
and other regions of migrating cells (Pertz, Hodgson, Klemke, & Hahn, 2006).
1.1.4.3.1 RhoA
Since RhoA promotes the formation of the contractile apparatus in migrating
cells—acto-myosin stress fibers, its activity is central to tension-dependent FA maturation
(Parsons, Horwitz, & Schwartz, 2010). RhoA is thought to promote intracellular tension
and FA maturation primarily through two effectors, Rho-associated kinase (ROCK) and
Dia. ROCK is a serine/threonine kinase which is activated upon binding to RhoA-GTP
(Bishop & Hall, 2000; Matsui et al., 1996). ROCK phosphorylates both myosin light chain
(MLC) and MLC phosphatase, increasing myosin II ATPase activity and inhibiting MLC
phosphatase activity to promote acto-myosin assembly and cellular contractility (Bishop
& Hall, 2000). Dia is a member of the formin-homology family of proteins that, upon relief
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of autoinhibition through RhoA-GTP binding, interacts with the barbed end of actin
filaments and associates with profilin to promote filament nucleation (Bishop & Hall, 2000;
F. Li & Higgs, 2003). Active RhoA is concentrated at the plasma membrane, both at the
rear of the cell where it contributes to acto-myosin contractility via ROCK and at the
leading edge of migrating cells where it interacts with Dia to promote actin polymerization
(Bishop & Hall, 2000; Kovar, Harris, Mahaffy, Higgs, & Pollard, 2006).
Rho family GTPases play an important role in the dynamic cytoskeletal
organization required for the cellular response to mechanical stimuli. The spatiotemporal
organization of these GTPases and resulting coordination between actin-based protrusion,
myosin II-mediated cellular contractility and microtubule dynamics is particularly
important for integrin-based adhesion and the mechanically regulated signaling pathways
downstream of these adhesions.
1.1.5 Integrins
Cells sense and exert force on their environment in part through the establishment
of physical connections between the ECM and force sensing and contractile machinery
within the cell. While several different adhesion molecules can mediate the interaction
between the cell and the ECM, among the best characterized are integrins. Integrins are a
family of heterodimeric transmembrane complexes comprised of an a and b subunit
(Hynes, 2002). Each subunit contains a large extracellular domain, single transmembrane
domain and short cytoplasmic tail (Harburger & Calderwood, 2009). As receptors for ECM
proteins such as fibronectin and laminin, integrins form the initial point of contact between
the cell surface and the ECM (Hynes, 2002). A wide variety of integrin complexes have
been characterized: 18 a and 8 b subunits associate in distinct ways to form 24 different
9

complexes (Zaidel-Bar, Itzkovitz, Ma’ayan, Iyengar, & Geiger, 2007). The extracellular
domains of these transmembrane proteins often recognize the conserved Arg-Gly-Asp
(RGD) domain in fibronectin and other ECM proteins and subtypes of the a and b subunits
can confer further selectivity between ligands (Humphries, Byron, & Humphries, 2006).
Integrins can bind to a wide variety of ECM ligands with different specificities which
allows the cell a fine degree of control over their adhesive state.
As the principal connection between the intra- and extra-cellular environments,
integrins play an important role in signal transduction across the cell membrane. Integrins
can exist in several conformations: bent-closed, extended-closed and extended-open,
which vary in binding affinity for their ligand and allow the integrin to be in an “active” or
“inactive” state (Shattil, Kim, & Ginsberg, 2010; Takagi, Petre, Walz, & Springer, 2002).
Where integrins exist along this continuum of active and inactive conformations is
influenced by binding partners both within and without the cell. Inside-out signaling occurs
when intracellular proteins such as talin or kindlin bind the cytoplasmic tail and cause a
conformational change to activate the integrin, increasing its affinity for ECM ligands
(Shattil et al., 2010; Takagi et al., 2002). Conversely, ECM ligands bound to integrin cause
a conformational change to activate the integrin, promote integrin clustering and trigger
downstream signaling, appropriately termed outside-in signaling. Inside-out and outsidein signaling collaborate to promote cellular adhesion and migration, and can precipitate
changes in cell signaling, polarity and gene expression.
Since the cytoplasmic tail of integrins are devoid of inherent signaling activity, they
rely on intracellular binding partners to transmit downstream signaling. The relatively short
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cytoplasmic tails of integrins associate with a wide range of proteins to facilitate the
formation of intracellular protein complexes, FAs.
1.1.6 Focal Adhesions (FAs)
1.1.6.1 Introduction to FAs
FAs are large protein complexes that physically connect ECM bound integrins to
the actin cytoskeleton (Fig 1). Recent proteomic screens have identified over 150 proteins
within FAs including integrin binding, cytoskeletal, and scaffolding proteins (Zaidel-Bar,
Itzkovitz, et al., 2007). This diverse set of molecules associate to form a dynamic signaling
hub that is subject to both intracellular and extracellular forces. Thus, FAs play a pivotal
role in mechanotransduction, which will be discussed later.
FAs provide the physical connection between the ECM and the contractile
cytoskeletal machinery of the cell. They are subject to forces generated by both actomyosin contractility as well as external forces on the cell and because of this play an
important role in modulating the tensional homeostasis between the ECM and the cell.
Accordingly, the nature of FAs is inherently tied to the contractile state of the cell and they
serve as mechanosensing units within the cell (Horton et al., 2015). Indeed, FAs are
dependent on a baseline level of cellular tension to exist. Inhibitors of cellular contractility
result in the rapid disassembly of mature FAs while cells plated on very soft substrates
form only very small adhesions (McKenzie et al., 2018; Wolfenson, Bershadsky, Henis, &
Geiger, 2011). Stiffening of ECM via collagen crosslinking by LOX enzymes promotes
FA assembly and signaling (Levental et al., 2009). Further, application of external force
results in the formation and reinforcement of FAs (Galbraith, Yamada, & Sheetz, 2002;
Riveline et al., 2001). FAs rely on a certain degree of cellular generated tension to mature.
11

This proceeds through the sequential recruitment of FA components, many of which
require cellular tension to be incorporated (Galbraith et al., 2002; Kuo, Han, Hsiao, Yates,
& Waterman, 2011; Oakes, Beckham, Stricker, & Gardel, 2012). Through a variety of
mechanisms that will be discussed below, FAs respond to force and activate signaling
cascades that can alter cell morphology, behavior, and gene expression.
FAs are classified based on their morphology, molecular makeup, and distribution
within the cell, all of which change across the lifetime of these dynamic structures.
Importantly, subtypes of FAs perform distinct roles in cell adhesion, spreading, migration
and matrix reorganization (Vicente-Manzanares & Horwitz, 2011).
1.1.6.2 FA Maturation
Adhesions required for cell spreading and directed cell migration begin as nascent
adhesions. These adhesions consist of ~50 integrins and their size is on the order of 100
nm, under the resolution (~.25 µm) of the light microscope (Changede, Xu, Margadant, &
Sheetz, 2015; Gardel, Schneider, Aratyn-Schaus, & Waterman, 2010). The majority of
nascent adhesions turnover rapidly, with a lifetime less than 60 seconds (Choi et al., 2008).
However, a subset of nascent adhesions remain and mature into focal complexes (~1 µm)
which may then in turn mature and elongate into FAs (~1-5 µm) (Gardel et al., 2010).
Mature FAs have lifetimes of 10-20 minutes and anchor either end of contractile actin
stress fibers (Gardel et al., 2010). In some cases, FAs further mature into fibrillar adhesions.
These elongated and dot-like structures differ in location and function from other adhesions
(Cohen, Addadi, & Geiger, 2004; Zamir et al., 2000); while important for matrix
reorganization, they are not the focus of the following discussion.
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Adhesion maturation is characterized not only by increases in size but by the
continued incorporation of new adhesion components. The precise differences in molecular
composition between distinct adhesion subtypes are less well defined than the differences
in size (Gardel et al., 2010). However, they serve to reinforce the connection between
integrins and the cytoskeleton and to promote downstream signaling. Recruitment of
components is thought to proceed in a hierarchical manner (Cohen et al., 2004).
Incorporation of new components is often dependent on force generated through either
actin polymerization, as is the case for focal complexes, or acto-myosin driven contractility
in the case of FAs (via the small GTPases Rac and RhoA, respectively) (Nobes & Hall,
1995).
For example, adhesions begin with activation and clustering of integrins following
the binding of intracellular partners like talin and kindlin or extracellular ligands like
fibronectin, as discussed previously (Calderwood, Campbell, & Critchley, 2013; Tadokoro
et al., 2003). These adhesions are located just along the edge of the cell and are comprised
initially of avb3 integrin and are high in phosphotyrosine (Cohen et al., 2004). Both paxillin
and FAK are recruited to early adhesions and phosphorylation on tyrosine residues
regulates adhesion maturation in part through recruitment of Rho family GTPase activators
(Choi, Zareno, Digman, Gratton, & Horwitz, 2011; Guilluy et al., 2011). Incorporation of
the actin bundling protein a-actinin and its actin crosslinking activity helps to establish a
connection to the actin cytoskeleton in focal complexes (Choi et al., 2008). Following this,
RhoA mediated acto-myosin contractility exerts force on adhesions and enhances
recruitment of adhesion proteins such as VASP, vinculin and zyxin (Choi et al., 2008;
Riveline et al., 2001; Wolfenson et al., 2011).
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Figure 1: FAs anchor ECM-bound integrins to acto-myosin stress fibers. REF52 cell
stained via immunofluorescence for paxillin (red) to visualize focal adhesions, the actin
cytoskeleton (green), and the nucleus (blue). FA structures link the actin cytoskeleton to
extracellular matrix bound integrins.
1.1.6.3 FA Disassembly
During cell spreading and cell migration, coordinated FA disassembly is as
important as the establishment of new adhesions. While FA assembly is relatively well
characterized, FA disassembly and turnover are comparatively less well understood, even
thought to differ based on adhesion location and type (Broussard, Webb, & Kaverina, 2008;
Vicente-Manzanares & Horwitz, 2011). Changes in tyrosine phosphorylation, cellular
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tension, proteolysis and microtubule dynamics have been implicated in disassembly
processes (Broussard et al., 2008; Crowley & Horwitz, 1995; Zaidel-Bar, Milo, Kam, &
Geiger, 2007).
The tyrosine kinase FAK (or Focal Adhesion Kinase, which will be highlighted as
a FA signaling protein later) plays an important role in the disassembly of adhesions.
Interestingly, FAK has been shown to both promote local decreases in cellular tension via
suppression of RhoA and increase cellular contractility through activation of ERK and
MLC kinase to promote adhesion disassembly (Schober et al., 2007; Webb et al., 2004).
At the rear of cells, myosin II dependent retraction of the trailing edge of the cell causes
FA “sliding” toward the center of the cell and disassembly (Crowley & Horwitz, 1995).
Activation of p190RhoGAP by the Abl related gene tyrosine kinase (Arg) has been shown
to promote FA disassembly as well (Peacock et al., 2007). These seemingly contradictory
examples highlight the complex role of tension in adhesion disassembly and need for
further study.
In addition to changes in phosphorylation and tension, proteolysis of adhesion
components has been shown to contribute to adhesion disassembly. The protease calpain
plays an important role in disassembly through interaction with several FA proteins and b3
integrin (Chan, Bennin, & Huttenlocher, 2010; Flevaris et al., 2007). For example,
inhibition of calpain-mediated talin cleavage leads to reduced FA turnover and increased
FA size (Bate et al., 2012; Franco et al., 2004).
Studies also point to a role for microtubules in regulation of FAs, particularly in
their disassembly. Microtubule tips have been shown to localize near FAs and the
microtubule depolymerizing drug nocodazole drastically alters FA morphology (Ezratty,
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Partridge, & Gundersen, 2005; Kaverina, Krylyshkina, & Small, 1999; Seetharaman &
Etienne-Manneville, 2019). Treatment with nocodazole results in rapid growth of FAs
while washout of the drug and subsequent growth of microtubules quickly results in FA
disassembly (Geiger, Avnur, Rinnerthaler, Hinssen, & Small, 1984; Seetharaman &
Etienne-Manneville, 2019). Besides shedding light on the regulation of FA disassembly,
this provides a unique experimental tool to separate adhesion assembly and disassembly,
the study of which is otherwise complicated by the inability to separate these two processes
(Bershadsky, Chausovsky, Becker, Lyubimova, & Geiger, 1996).
Microtubules are thought to play a role in targeting clathrin or adaptor proteins to
FAs to promote integrin endocytosis and may promote local decreases in tension to
disassemble adhesions (Broussard et al., 2008; Chao & Kunz, 2009; Ezratty, Bertaux,
Marcantonio, & Gundersen, 2009; Ezratty et al., 2005). It has also been shown that
microtubule-associated proteins increase FA disassembly through ECM degradation and
release of cell-ECM connections, underscoring the complexity of this interaction and need
for further study (Ezratty et al., 2009).
1.1.6.4 FA Components
As mentioned earlier, mature FAs are made up of upwards of 150 different proteins
(Zaidel-Bar, Itzkovitz, et al., 2007). While discussion of all of these is far beyond the scope
of this project, below we will discuss several important proteins relevant to this discussion
and illustrative of the diversity in function and form that comprises the FA proteome.
1.1.6.4.1 Talin
As the first FA protein discovered (K. Burridge & Connell, 1983; Horwitz, Duggan,
Buck, Beckerle, & Burridge, 1986), talin serves as the founding member of the diverse
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group of proteins that make up the FA proteome. It is a large protein (~2500 amino acids)
consisting of an N-terminal FERM domain, a flexible linker region, and a C-terminal rod
domain consisting of 13 helical bundles (Goult et al., 2013; Klapholz & Brown, 2017).
Talin directly binds to integrin cytoplasmic tails via its FERM domain where it plays a
crucial role in inside-out integrin activation and integrin clustering through its interaction
with RIAM (Calderwood et al., 2013; Goult et al., 2013). Within its rod domain talin also
contains several actin binding sites and thus acts as a vital linker to physically couple
integrins and the actin cytoskeleton (Klapholz & Brown, 2017; Muguruma, Matsumura, &
Fukazawa, 1990). Talin is directly subject to cellular force generated through actin-myosin
contractility and functionally reports the mechanical status of the integrin-actin interaction
through changes in protein binding. When under tension, the talin rod unfolds revealing
cryptic binding sites that promote the recruitment of other FA proteins (notably vinculin)
to strengthen the actin-integrin connection and promote FA maturation (Del Rio et al.,
2009). While talin is not required for initial cell spreading, it is indispensable to the
establishment of the mechanical linkage between ECM bound integrins and the actin
cytoskeleton required for downstream signaling (Zhang et al., 2008). As mentioned earlier,
talin undergoes calpain-mediated cleavage which is important for FA disassembly (Bate et
al., 2012; Franco et al., 2004). As such, the role of talin underscores major themes of FA
function including the physical coupling of actin and integrin and mechanosensitivity;
other FA proteins such as paxillin fulfill neither duty but still vitally contribute to FA
function.
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1.1.6.4.2 Paxillin
Paxillin is an important FA component that serves as an adaptor to scaffold other
proteins. In contrast with talin, paxillin does not directly connect actin and integrin but is
responsible for the recruitment and coordination of the activity of many FA components
required for downstream signaling. Paxillin is composed of multiple structural domains
which mediate its targeting to FAs, the membrane and much of its signaling activity
(Deakin & Turner, 2008). Paxillin is among the first proteins recruited to nascent adhesions
via binding to a4 integrin tails where it interacts with FAK (Choi et al., 2011; S. Liu et al.,
2002). Paxillin is regulated through phosphorylation on tyrosine, serine and threonine
residues by a constellation of kinases which lead to changes in localization, binding affinity
and assembly of signaling networks (Deakin & Turner, 2008; Webb et al., 2005). For
example, upon integrin activation paxillin is phosphorylated on several tyrosine residues
(Y31 and Y118) to recruit FAK and increase FA assembly and turnover (Zaidel-Bar, Milo,
et al., 2007). Paxillin phosphorylation also plays a major role in the spatiotemporal
coordination of Rho family GTPase signaling through its recruitment of regulatory proteins
such as GEFs and GAPs. Tyrosine phosphorylated paxillin promotes leading edge
protrusion by simultaneously activating Rac1 (through binding to a complex containing the
Rac1 GEF, DOCK180) and suppressing RhoA activity (through local increases in
p190RhoGAP) (Tsubouchi et al., 2002; Vallés, Beuvin, & Boyer, 2004). Thus, through its
capacity as an adaptor protein and changes in binding affinity mediated through
phosphorylation, paxillin plays an important role in the recruitment and stabilization of
other FA proteins. This inherent quality of paxillin highlights the importance of FAs in the
organization of signaling hubs. For FAs to function as signaling networks, they require the
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activity of signaling proteins, of which the previously mentioned FAK is among the best
characterized.
1.1.6.4.3 Focal Adhesion Kinase (FAK)
FAK is a nonreceptor protein tyrosine kinase that consists of an N-terminal FERM
domain, a kinase domain, proline rich regions, and a FA targeting (FAT) domain (Mitra,
Hanson, & Schlaepfer, 2005). FAK exists in an inactive autoinhibited form and is activated
downstream of integrin engagement and growth factor signaling which promote
autophosphorylation of Y397 and formation of a FAK/Src complex (Lietha et al., 2007).
While some kinase independent functions of FAK have been shown, active FAK is capable
of both scaffolding and kinase activity and is an important regulator of cell motility whose
expression is upregulated in many highly invasive cancers (Cance et al., 2000; Mitra et al.,
2005; Mitra & Schlaepfer, 2006). FAK activity has been shown to help coordinate the
activity of Rho family GTPases such as RhoA, Rac, and Cdc42, through the localized
activation of GEFs and GAPs (Tomar & Schlaepfer, 2009). The FAK/Src complex is
known to phosphorylate other scaffolding proteins such as paxillin and p130Cas which are
responsible for the recruitment of other FA components to adhesion sites (Mitra et al.,
2005).
As mentioned earlier, FAK plays a crucial role in the process of FA disassembly.
Knockdown of FAK results in larger FAs and slower rates of disassembly (Ilić et al., 1995).
It is thought that FAK may locally downregulate myosin contractility through transient
suppression of RhoA to increase FA disassembly (Ren et al., 2000; Schober et al., 2007).
FAK signaling at the cell front is necessary for activation of the MAPK/ERK cascade and
phosphorylation of MLC kinase which promote FA disassembly (Webb et al., 2004). FAK
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has been shown to increase disassembly through endocytosis of integrins (Ezratty et al.,
2005). FAK may also play a role in FA disassembly through association with calpain to
promote proteolytic cleavage of FA proteins such as talin (Bate et al., 2012; Mitra et al.,
2005).
1.1.7 Mechanotransduction
Cells are routinely subject to mechanical forces in their environment that are
specific to their physiological niche and can be altered during pathological states. These
forces are an indispensable source of information taken in by the cell to inform and alter
cellular behavior. Interestingly, despite the variety of forces that cells are exposed to within
tissues, the cellular mechanosensing and response elements that mediate downstream
signaling are largely consistent (Hoffman, Grashoff, & Schwartz, 2011). This can be
attributed to the fact that the cellular machinery that bears and generates force also initiates
downstream signaling within this pathway (Discher, Janmey, & Wang, 2005). While
mechanosensitive ion channels play a large role in processes such as blood flow regulation
(J. Li et al., 2014), here we focus on the mechanotransduction pathways associated with
FAs and the cytoskeleton, and how they change cellular behavior in response to alterations
in ECM rigidity.
Mechanotransduction and the cellular response to rigidity is a complex process that
can be broken down into several general steps (Vogel & Sheetz, 2006). Initial
mechanotransmission occurs when a force is transmitted across mechanosensitive
structures within the cells. This is achieved through the interconnected structure that
comprises the ECM-integrin-FA-cytoskeletal linkage. These structures are involved in
mechanosensation, as transmitted forces alter the molecular conformation of
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mechanosensitive proteins and change their activity. This directly contributes to the
cellular mechanoresponse, as force induced conformational changes propagate across the
cellular landscape to affect downstream signaling pathways (in some cases gene
transcription) that are not necessarily mechanosensitive in and of themselves (Hoffman et
al., 2011).
1.1.7.1 Slip Bonds and Catch Bonds
Changes in force can influence the strength of molecular binding. Protein: protein
interactions typically display what is known as “slip-bond” behavior. When exposed to
high forces, the bond between these molecules is not strong enough to resist the force
applied, and the bond breaks. Less intuitively, many mechanosensitive molecules interact
via “catch-bonds”, where applied force alters protein conformation and results in a
strengthening and prolongation of the bond lifetime. This is the case between actin and
myosin (Guo & Guilford, 2006) and a5ß1 integrin and fibronectin (Kong, García, Mould,
Humphries, & Zhu, 2009). Importantly, “catch-bonds” allow associations between
mechanosensitive molecules to persist and strengthen under tension and promote
downstream signaling pathways in response to increased force.
1.1.7.2 Protein Domain Unfolding
In addition to affecting bond strength, changes in force can alter protein
conformation to unmask binding and phosphorylation sites. Many mechanosensitive
proteins undergo domain unfolding when exposed to force, where stretching the molecule
reveals cryptic binding sites within the protein. Fibronectin-bound integrins transmit
cellular generated force and cause conformational changes in the fibronectin molecule.
This force exposes fibronectin binding sites and promotes fibronectin fibril assembly
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(Singh et al., 2010). Indeed, the formation of fibronectin fibrils within the ECM depends
on cellular generated force through this mechanism (Zhong et al., 1998). Another wellstudied illustration of this is the force dependent interaction between talin and vinculin.
When talin is exposed to force, the talin rod unfolds, revealing cryptic vinculin binding
sites (Del Rio et al., 2009). Vinculin binding to talin activates vinculin and disturbs the
interaction between talin and RIAM, resulting in stabilization of adhesion complexes
(Goult et al., 2013). Mechanosensitive protein domain unfolding under force can also
reveal buried post translational modification sites. For example, stretching of p130Cas
increases its phosphorylation on tyrosine residues by Src family kinases (Sawada et al.,
2006).
1.1.7.3 Reversible Phosphorylation
Reversible phosphorylation of proteins is one of the most important signal
transduction events within FA mechanotransduction. Many, if not all FA components
undergo some degree of reversible phosphorylation to regulate their activity and function
(Robertson et al., 2017). Tyrosine phosphorylation is especially common within FAs,
accounting for approximately 30% of phosphorylation in isolated adhesion fractions
despite only making up 2% of phosphorylation within the whole cell (Robertson et al.,
2017). For this reason, tyrosine phosphorylation has been particularly well studied in
regard to cell adhesion and often serves as a marker for adhesion structures within the cell
(Cohen et al., 2004; Zamir et al., 2000; Zimerman, Volberg, & Geiger, 2004). One of the
first demonstrations of signaling associated with cell-ECM engagement was an increase in
tyrosine phosphorylation following ß1 integrin activation (Kornberg, Earp, Turner,
Prockop, & Juliano, 1991). Several well-characterized tyrosine kinases localize to FAs
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including FAK (discussed earlier), Src, Abl and Csk (Geiger & Zamir, 2001). Importantly,
many central FA components (talin, paxillin, FAK, p130Cas etc.) are regulated through
tyrosine phosphorylation which alters protein localization, activity, and binding partners
(Robertson et al., 2017; Webb et al., 2004; Zaidel-Bar, Milo, et al., 2007).
Despite the demonstrated importance of tyrosine phosphorylation in the regulation
of FA dynamics, serine and threonine phosphorylation are comparatively much more
abundant and far less studied (Robertson et al., 2017). Indeed, every FA protein which
undergoes tyrosine phosphorylation is also phosphorylated on serine and threonine
residues (Robertson et al., 2017). The breadth of serine and threonine phosphorylation
present within FAs represents a vastly understudied area in the understanding of FA
regulation and mechanotransduction. For reasons discussed below, our lab is particularly
interested in the role(s) that the cAMP dependent kinase-A (protein kinase A, or PKA)—a
prototypic serine/threonine kinase, may have in the regulation of FA dynamics and cellular
mechanotransduction.
1.2 Protein Kinase A (PKA)
1.2.1 PKA Structure and Function
PKA is among the most well characterized and ubiquitous signaling enzymes
within the cell. PKA exists as a heterotrimeric holoenzyme in its inactive form, composed
of two regulatory and two catalytic subunits. Four genes encode for four different
regulatory (R) subunits (RIa, RIß, RIIa, RIIß) while 3 genes encode 3 catalytic (C)
subunits (a, ß, γ). While the 3 C subunits exhibit essentially identical kinetic and
physiochemical properties, the different R subunits have different cAMP binding affinities
and localization throughout the cell and mediate dimerization and anchoring (Howe, 2004).
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Type I PKA (RI subunits) is typically cytoplasmic, while type II PKA (RII subunits) more
often localized to specific structural subdomains and organelles within the cell (Corbin,
Sugden, Lincoln, & Keely, 1977; Scott, Dessauer, & Tasken, 2013). In the absence of
cAMP, the R subunits maintain the C subunits in their inactive state. Canonically, kinase
activity is initiated upon induction of cAMP by adenylyl cyclase whereby four molecules
of cAMP bind to the R subunits of the tetrameric holoenzyme. This causes a
conformational change and releases the C subunits which locally phosphorylate serine and
threonine residues. Recent work challenges this classical paradigm suggesting that
catalytically active PKA may remain as an intact holoenzyme, and that the kinase acts in a
far more spatially restricted manner than previously thought (Smith et al., 2017). This
becomes increasingly important as the broad spectrum of PKA signaling throughout the
cell requires the ability to finely tune, spatially and temporally, the activity of this
promiscuous kinase.
1.2.2 A Kinase Anchoring Proteins (AKAPs)
Spatial and temporal restriction of PKA signaling is realized through the interaction
of the R subunits of the PKA holoenzyme with a large family of proteins called A Kinase
Anchoring Proteins (AKAPs) (Smith & Scott, 2006). This structurally diverse family of
proteins is unified by their ability to bind and scaffold PKA, spatially restricting and
directing PKA activity to a specific cellular subdomain. The vast majority of the more than
50 identified AKAPs interact with the PKA holoenzyme via a 14-18 amino acid sequence
which forms an amphipathic helix binding motif (although some AKAPs do exhibit
noncanonical binding) (Welch, Jones, & Scott, 2010). There are both RI specific and RII
specific AKAPs, as well as AKAPs with dual specificity (Welch et al., 2010).
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Importantly, AKAPs not only anchor PKA within specific subcellular
compartments but also organize complex signaling hubs within the cell (Fig 2). AKAPs
allow for both spatial AND temporal restriction of PKA by binding a wide array of
signaling components including activators, effectors, substrates and signal termination
enzymes (such as phosphodiesterases (PDEs) and phosphatases (P’ase) (Howe, 2004;
Welch et al., 2010). The localization of PKA via AKAPs facilitates specific activation of
PKA in subcellular compartments allowing it to act locally within diverse signaling
cascades throughout the cell. In this way, AKAPs organize “signaling islands” which focus
and insulate PKA activity allowing it to respond to specific local stimuli. This
organizational motif is critical to a broad range of PKA-dependent cellular processes, and
plays an important role in directing PKA regulated cell adhesion and migration (Howe,
2004; McKenzie, Campbell, & Howe, 2011).

Figure 2: Paradigm for localized PKA signaling by AKAPs. (adapted with
permission from A. Howe) PKA activity is specified in subcellular space through
interaction with AKAPs. AKAPs anchor PKA via regulatory (R) subunits to subcellular
structures and form signaling islands composed of PKA substrates and signal
termination enzymes such as phosphodiesterases (PDE) and phosphatases (P’ase).
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1.2.3 PKA in Cytoskeletal Regulation and Cell Adhesion
Among its myriad functions, PKA exerts multi-faceted control over a constellation
of processes involved in cytoskeletal regulation and cell adhesion (Howe, 2004).
Interestingly, studies have revealed both a positive and negative influence of PKA on
different aspects of adhesion and migration. For example, PKA is both required for (Edin,
Howe, & Juliano, 2001) and inhibitory to (Ydrenius, Molony, Ng-Sikorski, & Andersson,
1997) cell migration. Our lab and others have demonstrated the presence of a dynamic and
localized pool of PKA at the leading edge of migrating cells which we have recently shown
to be dependent on intracellular tension (Lim et al., 2008; McKenzie et al., 2011;
McKenzie, Svec, Williams, & Howe, 2020). PKA has also been shown to play a role in
other cellular regions important to efficient cell migration including the trailing edge (Jones
& Sharief, 2005), actin cytoskeleton (Howe, 2004), and at adhesion structures themselves
(Howe, Balder, & Hogan, 2005; Lim et al., 2007). While these and other notable
connections between cytoskeletal regulation, adhesion and PKA have been extensively
reviewed (Howe, 2004), several relevant examples will be summarized below.
1.2.3.1 PKA in Cytoskeletal Regulation
PKA is intimately tied to cytoskeletal regulation through a host of substrates
involved in these processes, including both structural and regulatory proteins (Howe,
2004). PKA is capable of phosphorylating actin directly, an effect which was shown to
decrease the ability of actin to polymerize (Ohta, Akiyama, Nishida, & Sakai, 1987). PKA
also exerts control over MLC at several levels to affect myosin-based contractility. MLC
phosphorylation affects its binding to F-actin and is regulated through the balance in
activity of MLC kinase and MLC phosphatase (Howe, 2004). While complicated, it is
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thought that PKA influences MLC by altering this balance and this relationship has been
the subject of several reviews (Abdel-Latif, 2001; Pfitzer, 2001).
PKA also has a well-documented role connecting it to prominent regulators of the
cytoskeleton, including the Rho family GTPases Rac1, Cdc42, and RhoA (Howe, 2004).
PKA binds Rac1 and is required for Rac1 activity, likely through effects on Rac GAPs and
GEFs (Adame-García et al., 2019; Bachmann et al., 2013; Howe et al., 2005). PKA has
also been shown to stimulate Cdc42, although it does not directly phosphorylate it
(Feoktistov, Goldstein, & Biaggioni, 2000).
Perhaps the most direct evidence connecting PKA to cytoskeletal regulation comes
from its well characterized interaction with RhoA. Unlike Rac1 and Cdc42, PKA directly
phosphorylates RhoA on Ser188 (Lang et al., 1996). This modification increases RhoA
interaction with Rho-GDI, which restricts RhoA to the cytosol and prevents its activation
(Ellerbroek, Wennerberg, & Burridge, 2003; Lang et al., 1996). It has also been shown that
phosphorylation of RhoA by PKA may protect it from ubiquitin-mediated proteasomal
degradation (Rolli-Derkinderen et al., 2005). Functionally, PKA mediated phosphorylation
of RhoA has also been shown to regulate an important protrusion-retraction cycle in the
leading edge of migrating cells (Tkachenko et al., 2011). PKA activity at the leading edge,
which depends on cell adhesion, phosphorylates active RhoA within protrusive regions and
increases its affinity for RhoGDI leading to a decrease in protrusion duration and the
retraction necessary for efficient cell migration (Tkachenko et al., 2011).
1.2.3.2 PKA in Cell Adhesion
PKA not only plays an important role in regulation of cytoskeletal organization but
its activity is influenced by changes in cell adhesion. Upon detachment of adherent cells,
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PKA activity rapidly increases, and its activity is required for regulation of tyrosine
phosphorylation of FA components paxillin and FAK (Howe & Juliano, 2000). This
detachment stimulated PKA activity also results in phosphorylation of VASP, a regulator
of actin dynamics that localizes to FAs (Howe, Hogan, & Juliano, 2002). Following
replating on fibronectin, PKA activity gradually increases and peaks after 40 minutes, an
event which is correlated with increased phospho-VASP which disrupts its interaction with
the tyrosine kinase Abl (Howe et al., 2002).
PKA is activated upon cell detachment; conversely, PKA has also been shown to
be activated following integrin engagement. PKA activity increases following ß1 integrin
activation (Whittard & Akiyama, 2001). This study also showed that PKA colocalized with
active ß1 integrins and was required for both actin polymerization and integrin clustering
downstream of ß1 integrin activation (Whittard & Akiyama, 2001). However, PKA
activation downstream of integrin engagement seems to be both cell-type and ECM ligand
specific (Howe, 2004). PKA is further linked to integrin adhesion through its interaction
with a4 integrin, an established PKA type I specific AKAP (Lim et al., 2008). PKA is both
anchored by and phosphorylates a4 preferentially at the leading edge of migrating cells
which prevents binding of paxillin and is required for efficient a4-mediated migration
(Goldfinger, Han, Kiosses, Howe, & Ginsberg, 2003).
In addition to PKA regulation by cell adhesion, adhesion complexes also contain a
number of bona fide PKA substrates. These include VASP family proteins (Howe et al.,
2002; Sechi & Wehland, 2004), a4 integrin (Goldfinger et al., 2003) mentioned above, and
Src family kinases (Src (Armaiz-Pena et al., 2013) and Fyn (Yeo et al., 2011)), among
others. Notably, none of the known targets for PKA fully explain its effects on cell adhesion
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and it is likely that PKA acts in other ways to influence adhesion complexes. Given the
existence of mechanoresponsive pools of PKA activity elsewhere in the cell (McKenzie et
al., 2020) it is tempting to postulate a role for PKA within such central mechanosensitive
cellular subdomains such as FAs. Indeed, proteomic analyses have identified both R and C
subunits of PKA within isolated adhesion fractions as well as a high prevalence of
understudied serine/threonine phosphorylation events (Horton et al., 2015; Kuo et al.,
2011; Robertson et al., 2017). Unpublished data from our lab utilizing a FA targeted PKA
biosensor reveal discrete and highly dynamic patterns of PKA activity within individual
FAs (H. Naughton & A. Howe, unpublished data). Further, our lab has preliminary data
that reveals a potential AKAP centrally located within FAs (M. Kang & A. Howe,
unpublished data). Given this evidence suggesting a yet undescribed role for PKA within
FAs, this thesis aims to characterize the effects of PKA activity on FAs and gain insight
into the signaling pathways it controls.
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CHAPTER 2: Materials and Methods
2.1 Cell Culture and Reagents
2.1.1 Cell Culture
Rat embryonic fibroblasts (REF52) and human diploid fibroblasts (HDF) were
obtained from the American Type Culture Collection and maintained in a humidified
incubator at 37˚C containing 5% CO2 in antibiotic-free Dulbecco’s Modified Eagle’s
medium (DMEM) supplemented with 10% (v/v) fetal bovine serum. Cells were trypsinized
and split 1:10 every 2-3 days to avoid reaching confluence.
2.1.2 Reagents
Reagents for immunofluorescence were purchased from Abcam (Paxillin Y113,
ab32084; Donkey Anti-Rabbit Alexa Fluor 594, ab150064) and Invitrogen (Alexa Fluor
488 Phalloidin, A12379). The PKA inhibitor 8-[(4-chlorophenyl)thio]-adenosine cyclic
3',5'-[hydrogen (R)-phosphorothioate] (Rp-8-CPT-cAMP, “Rp-cAMPs”) was purchased
from Biolog (Hayward, CA). Human fibronectin was purchased from BD Biosciences
(Bedford, MA). The microtubule depolymerizing agent nocodazole was purchased from
Biomol (Hamburg, Germany). Acrylamide and N,N’-Methylenebisacrylamide were
purchased from National Diagnostics (Atlanta, GA). Tetramethyl-ethylenediamine
(TEMED), ammonium persulfate (APS), and DMSO were purchased from Sigma (St.
Louis, MO). N-Sulfosuccinimidyl-6-(4'-azido-2'nitrophenylamino) hexanoate (SulfoSANPAH) was purchased from CovaChem (Loves Park, IL).
2.1.3 Plasmids and Transfection
Plasmids used here include pcDNA3.1/mycHis(-)A (Invitrogen), pCMVmycRhoAwt, pCMVmyc-RhoA(S188A), and Optogenetic Localization of A Kinase to Focal
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adhesions (OLAF) constructs: OptoPKAW196R/Y204Ag and pCIBN mCherry-Paxillin.
RhoAwt and RhoA(S188A) plasmids were a gift from Dr. Shawn Ellerbroek (Wartburg
College). The plasmid encoding mCherry-paxillin was made by substituting mCherry for
EGFP in pEGFP-N1-paxillin (a gift from Dr. Chris Turner (SUNY, Upstate)). OLAF
constructs were derived from OptoPKA (Cry2-mCh-PKA-CW196R/Y204A) developed by
Banion et al (2017) and CIBN-ΔNLS-pmGFP and obtained from Addgene (plasmid #
104546 and 26867, respectively). Here we have adapted these constructs to target PKA to
FAs via paxillin and have generated Opto-PKAg and pCIBN-mCherry-Paxillin. These
alterations were made principally to allow us to monitor FA dynamics via mCherry-paxillin
without necessarily activating localization of OptoPKA.
Cells were transfected using Fugene6 (Promega) according to the manufacturer’s
protocol. Briefly, cells were plated into 35 mm dishes at 60-70% confluence the day prior
to transfection so that they were ~80% confluent at the time of transfection. Fugene6 and
Opti-MEM (ThermoFisher) were warmed to room temperature and 4 µl of Fugene6 was
diluted into Opti-MEM so that the final volume of transfection solution (including 1 µg of
DNA) was 100 µl. Fugene6 and Opti-MEM were mixed by trituration and incubated for 5
minutes at room temperature. A total of 1 µg of plasmid DNA was added to the diluted
Fugene6 at a 1:4 ratio (DNA: Fugene6) and mixed by gently flicking the tube then
incubated for 20 minutes at room temperature. The transfection solution was added
dropwise to the cells. Cells were imaged 48-72 hours post transfection, optimized
depending on the cell line and plasmid expression.
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2.2 Microscope Optics
All fixed and live cell imaging was performed on a Nikon TiE series inverted
microscope equipped with an Andor Clara charged coupled device camera (Andor
Technologies, South Windsor, CT) controlled by Elements (Nikon) software unless
otherwise noted. The appropriate fluorophore specific filters (Chroma Technology Corp,
Rockingham, VT) used are described below. Red fluorescent fluorophores (mCherry,
donkey anti-rabbit Alexa Fluor 594, red fluorescent Fluospheres) were imaged with Texas
Red HYQ (555 l) with excitation filter (532-587 nm, 55) and emission filter (608-683 nm,
75). Green fluorescent fluorophores (GFP, optoPKAg, phalloidin 488) were imaged with
FITC (470 l ) with excitation filter (480 nm, 30) and emission filter (535 nm, 45).
2.3 Immunofluorescence
2.3.1 Cleaning Coverslips
22 mm glass coverslips (Electron Microscopy Services) were placed in a ceramic
coverslip holder and sterilized by incubating in 2% HCl at 70˚C for 30 minutes, washed in
ddH2O 2x10 min, incubated in a solution of 2% cuvette cleaning concentrate in ddH2O at
50˚C for 30 minutes, and washed again in ddH2O 2x10 min. The coverslips were incubated
in ddH2O at 90˚C for 30 minutes, then in 70% ethanol at 70˚C for 10 minutes and allowed
to airdry at 60˚C overnight. Dry coverslips were stored in 70% ethanol until ready to use.
2.3.2 Plating Cells
Cleaned coverslips were removed from 70% ethanol and allowed to dry in a
biosafety cabinet. Coverslips were placed into 35 mm wells of a 6 well plate and incubated
with 10 µg/ml fibronectin (BD Biosciences) at 37˚C for 1 hour, or overnight at 4˚C.
Coverslips were washed 3 times with PBS and prewarmed at 37˚C before plating cells.
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Cells were trypsinized, resuspended in DMEM supplemented with 1% FBS and plated at
indicated densities for the specified time period before fixation.
2.3.3 Fixation
For visualization of paxillin and actin, culture medium was removed and cells were
fixed in freshly prepared 4% formaldehyde in PBS for 15 minutes at room temperature,
washed twice with PBS, permeabilized with PBS containing 0.25% Triton X-100 for 10
minutes at room temperature and washed twice with PBS. The coverslips were blocked in
PBS containing 5% normal donkey serum (Jackson ImmunoResearch) for 1 hour at room
temperature or overnight at 4˚C. The cells were then incubated with primary antibody:
rabbit anti-paxillin (1:200, Abcam) in a humidified staining chamber for 1 hour at room
temperature or overnight at 4˚C. After 3x5 min washes in PBS, cells were incubated with
secondary antibodies: donkey anti-rabbit Alexa Fluor 594 (1:400), Alexa Fluor 488
Phalloidin (1:40 from 66 µM stock solution, Invitrogen) for 1 hour at room temperature.
After 3x5 min washes in PBS, coverslips were mounted onto glass microscope slides
(Fisher) using a small volume of PermaFluor mountant (Thermo Scientific) or in-house
made mounting medium (https://nic.med.harvard.edu/resources/media/). Epifluorescence
images were captured through a 40x Plan Apo objective on the inverted microscope
described above.
2.4 Quantification of FA Area
Images of fixed REF52 and HDF cells taken using the 40x oil immersion objective
were

analyzed

using

a

custom

macro

created

in

FIJI

(ImageJ

https://imagej.nih.gov/ij/index.html). Briefly, images were imported into the program and
underwent median filter processing (radius = 1.5) and background subtraction (rolling ball
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radius = 50). The images were then thresholded to produce a binary image which would
allow for identification of FAs and analysis of area and shape descriptors. In order to
maintain some degree of automaticity while still considering cell-cell variation, the macro
was written to produce several thresholded images in which the lower threshold was set
anywhere from 9-15 times the mean of the background subtracted image. The most
representative thresholded image was selected manually for analysis. Representative
images were produced by thresholds across this spectrum regardless of timepoint, cell line,
or treatment. FA area measurements and shape descriptors were calculated from the binary
image using the analyze particles function in FIJI. Graphs and statistical analyses were
produced using GraphPad Prism Software.
2.5 Live Cell Imaging of Traction Forces in Spreading Cells
2.5.1 Plating Cells
REF52 cells (untransfected or expressing indicated plasmids) were trypsinized and
the desired volume of cells (~25,000 cells/35 mm dish) was suspended in DMEM (10%
FBS) and spun down at 1200 rcf in a tabletop centrifuge at room temperature for 5 minutes.
DMEM was aspirated off, taking care not to disturb the cell pellet, and cells were
resuspended in 2 mL Ringer’s buffer supplemented with 1% FBS.
PKA inhibitor, Rp-8-CPT-cAMPs (“Rp-cAMPs”, 75 µM) or 15 µl sterile H2O was
added to cell suspension and gently mixed by trituration. Cell suspension was then plated
onto prewarmed fibronectin coated 125 kPa traction force gels (described below). Cells
were returned to the tissue culture incubator and allowed to adhere for 20 minutes prior to
imaging.
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2.5.2 Fabrication of Traction Force Gels
Traction force gels were prepared as described in Svec et al. (2019). Briefly, glass
bottom imaging dishes (35 mm with 20 mm glass well, Cellvis) were activated by mixing
a solution of 950 µl 95% ethanol, 50 µl glacial acetic acid, and 5 µl of bind silane (γmethacryloxypropyltrimethoxysilane), activating the surface of the glass for 20 seconds
with a corona wand and immediately overlaying 50 µl of the bind silane solution before
allowing the glass to dry for 10 minutes. Imaging dishes were then washed twice with 95%
ethanol and twice with isopropanol and allowed to dry for approximately 20 minutes.
Activated coverslips were stored for up to 1 week in a desiccator or used immediately.
Stock solution of FluoSpheres carboxylate-modified nanospheres (0.2 µm, red
fluorescent, ThermoFisher Scientific) were sonicated in an ultrasonic water bath for 1 hour.
A working bead solution was made by diluting the bead stock at 1:50 in 100% ethanol to
capture high resolution traction forces under spreading cells. The working bead solution
was then sonicated for 1 hour. An 18 mm coverslip (Fisher) was placed in a ceramic
coverslip holder and treated with room-air plasma for 3 minutes in a tabletop plasma
cleaner (Harrick Plasma). The coverslip was placed in a Parafilm covered 60 mm cell
culture dish lid and lightly tapped down to prevent sliding of the coverslip. The coverslip
was overlaid with 150 µl of working bead solution which was immediately aspirated off
and the coverslip allowed to air dry.
To cast the 125 kPa hydrogels, a hydrogel solution was prepared consisting of 160
µl 7.5% acrylamide, 0.5% Bis-Acrylamide and 137 µl ddH2O. 2.5 µl of 10% APS and 0.5
µl of TEMED were added to the hydrogel solution and mixed by trituration. Immediately,
25 µl of hydrogel solution was added to the surface of an activated glass bottom dish and
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the fluorescent nanosphere-coated coverslip laid onto the hydrogel drop. The glass bottom
dish was flipped over to ensure even settling of the bead field and the gel was allowed to
polymerize for 30 minutes. The dish was flipped over following polymerization and 50
mM HEPES pH 8.5 was poured into the dish and the top coverslip popped off with forceps.
The gel was then washed 3X5 min in 50mM HEPES pH 8.5. (Note: 50 mM HEPES pH
8.5 should be prepared fresh from powder to avoid issues with cell adhesion after plating.)
To activate the hydrogel surface, a solution of 0.4 mM sulfo-SANPAH in 50 mM
HEPES pH 8.5 was added to the dish which was immediately transferred to a prewarmed
UV arc lamp (Uvitron International) and exposed for 90 seconds at 100% power. The
hydrogel was then removed from under the lamp, the sulfo-SANPAH solution aspirated
off and the gel was washed 3X5 min in 50 mM HEPES. The hydrogel was then incubated
with 20 µg/mL fibronectin in 50 mM HEPES pH 8.5 for 1 hour at 37˚C. The fibronectin
solution was removed and washed 3x5 min in PBS. The hydrogel and the lid of the dish
were sterilized for 15 minutes under the UV light of a biosafety cabinet in 2 mL PBS. The
hydrogel was washed once in sterile PBS and stored at 4˚C for up to one week or transferred
to the cell culture incubator and prewarmed prior to plating cells.
2.5.3 Traction Force Imaging
Cells were plated onto traction force gels for assessment of traction forces during
spreading identically to those in other cell spreading assays described above. After
adhering to the gel for 20 minutes, the cells were transported to the Howe Laboratory
Microscope Room for imaging on the inverted microscope described above. Culture
temperature was maintained at 35–37°C with hot air (ASI 400 Air Stream; Nevtek).
Fluorescent nanosphere images and phase contrast cell images were captured every 30
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minutes for 2.5 hours, beginning 30 minutes after plating. After this period, cells were
cleared by the addition of 5% SDS and null bead fields captured for each cell. As previously
described (Svec, Patterson, Naim, & Howe, 2019), fluorescent nanosphere images were
registered to correct for any stage drift, and the movement of individual nanospheres
between image pairs was calculated with an ImageJ traction force microscopy plugin
developed by Qingzong Tseng (https://sites.google.com/site/qingzongtseng/tfm) which
uses Particle Image Velocimetry (PIV) and the Young’s elastic modulus of the
polyacrylamide hydrogels (125 kPa) to calculate traction forces using Fourier Transform
Traction Cytometry (FTTC).
2.6 Nocodazole Washout Assay
REF52 cells were plated on FN coated coverslips in the presence or absence of 75
µM Rp-cAMPs. The cells were then left untreated or incubated with 10 µM nocodazole
for 2 hours and then fixed or incubated with 10 µM nocodazole for 1.5 hours after which
the drug was washed out and cells were refed with media and microtubules allowed to
repolymerize for 20 minutes in the presence or absence of 75 µM Rp-cAMPs prior to
fixation. The cells were then stained for paxillin and imaged as described previously.
2.7 OLAF (Optogenetic Localization of A kinase to Focal Adhesions)
To visualize changes in FA dynamics upon recruitment of active PKA to FAs,
REF52 cells transiently expressing the OLAF constructs were plated onto fibronectin
coated glass bottom imaging dishes and allowed to adhere for four hours prior to imaging.
Cells were then transferred for imaging to the Howe Lab Microscope Room for imaging
on the inverted microscope described above. Culture temperature was maintained at 35–
37°C with hot air (ASI 400 Air Stream; Nevtek). Cells expressing both constructs and
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showing localization of OptoPKAg upon illumination with 470 l were selected for further
imaging. The cells were monitored over the course of 3 imaging periods. During the first
imaging period, FA dynamics were captured via pCIBN-mCh-Paxillin every 30 seconds
for 15 minutes in the absence of opto-PKA localization. During the second period
(“activation”), the cells were stimulated with 470 l every 5 seconds to stimulate and
maintain opto-PKAg localization to FAs, and pCIBN-mCh-Paxillin acquired every 30
seconds (i.e. every 6th 470 l stimulation) for 15 minutes. The third imaging period was
identical to the first and acquired pCIBN-mCh-Paxillin images every 30 seconds for 15
minutes in the absence of 470 l illumination. As a control for this optogenetic activation
procedure, this 3 phase imaging series was repeated with the omission of 470 l excitation
during the “activation phase”; pCIBN-mCh-Paxillin images alone were acquired every 30
seconds for 3 15-minute sequential imaging periods.
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CHAPTER 3: Results
3.1 Inhibition of PKA changes FA morphology in spreading REF52 and HDF cells
As discussed earlier, several lines of evidence including the presence of PKA within
purified FAs, as well as promising results from an ongoing investigation in our lab to
identify FA-specific AKAPs prompted us to explore how PKA activity influences FAs. To
begin this investigation, we plated Rat Embryonic Fibroblast (REF52) cells on fibronectin
coated glass coverslips in the presence and absence of the specific inhibitor of PKA, Rp8-CPT-cAMPs (“Rp-cAMPs”, 75 µm). This cAMP analogue binds to cAMP sites on the
R subunit of PKA and prevents dissociation of the holoenzyme and kinase activity
(Dostmann et al., 1990). While overall cell and FA morphology can be variable in cells
which are fully spread and polarized on their substrate, newly spreading cells offer a
comparatively more homogenous population in which to investigate morphological
differences in FAs. In order to capture changes in FAs throughout the duration of cell
spreading, REF52 cells were fixed 30, 60, 90, 120 and 180 minutes after plating and stained
for paxillin (Fig 1A and 1B), a FA protein which localizes to adhesion structures
throughout their lifetime.
At 30 minutes, control and +Rp-cAMPs treated cells had similar morphology; the
majority of cells in each group were small and round (Fig. 1A and 1B), typical of cells
early in spreading (Bell, Redmann, & Terentjev, 2019). Many of the cells in each group
were decorated with small paxillin-positive adhesions around the perimeter of the cell. At
60 minutes (Fig 1A and 1B), the control and treated cells remained similar in size and
adhesion morphology. The cells were generally circular with larger overall area than the
previous timepoint. Adhesions at the 60-minute time point were often observed in small
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Figure 1: PKA inhibition changes FA morphology in spreading REF52 cells

Figure 2: PKA inhibition changes FA morphology in spreading HDF
cellsFigure 1: PKA inhibition changes40
FA morphology in spreading REF52
cells

Figure 1. PKA inhibition changes FA morphology in spreading REF52 cells.
(A) REF52 cells plated on fibronectin coated glass in the absence (control) and presence
of the selective PKA inhibitor (+Rp-cAMPs) were fixed 30, 60, 90, 120 and 180 minutes
after plating and stained for paxillin. (B) Insets from cells highlighting morphological
differences between groups upon treatment with Rp-cAMPs. (C-E) Immunofluorescence
images were analyzed at 90, 120 and 180 minutes to determine FA size (C-D) and aspect
ratio (E). (C) Depicts all measured adhesion values at each timepoint. (D) Depicts all
measured adhesion values greater than 15 μm2 to highlight differences at larger adhesion
area values. (E) Depicts mean aspect ratio for all groups (n = >170 cells from 2
experiments; *p<.05, *** p<.001, **** p<.0001)
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clusters, with some individual adhesions present. At 90 minutes, while the majority of the
cells in the control group had smaller easily discernable individual adhesions, the cells
treated with Rp-cAMPs more often had clusters of adhesions that were larger and longer
than those of control cells. These differences persisted at 120 and 180 minutes after plating.
To quantify these observations, we used a custom written ImageJ macro to threshold and
measure FA morphology. Briefly, images were imported into ImageJ, preprocessed to
promote visualization of adhesions and thresholded to produce a binary image from which
adhesion area and shape descriptors were quantified. FAs in cells treated with Rp-cAMPs
were significantly larger than FAs in control cells at 90, 120 and 180 minutes after plating
(Fig 1C and 1D). In addition, FAs in cells treated with Rp-cAMPs had significantly larger
aspect ratios than control cells (Fig 1E). These data show that inhibition of PKA activity
alters FA morphology in spreading REF52 cells at 90, 120 and 180 minutes after plating.
To expand this observation, we repeated this experiment in another fibroblast cell
line, Human Diploid Fibroblasts (HDF)s (Fig 2). At 30 minutes, control and +Rp-cAMPs
cells displayed small and round morphology, with a dense ring of paxillin staining around
the perimeter of the cell (Fig 2A). Comparisons at this early timepoint between HDF and
REF52 cells highlight slower spreading and adhesion development that was routinely
observed in HDFs when compared with REF52 cells. Indeed, at the 60-minute timepoint,
many of the HDFs in each treatment group still showed this ring of paxillin positive
adhesions around the periphery of the cell. While some cells were beginning to show breaks
in this ring and the formation of clusters of adhesions, it was evident that the majority of
HDFs attached and spread on this substrate more slowly than REF52 cells. Following this
timepoint we observed quite a bit more variability in overall cell shape and morphology in
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Figure 2: PKA inhibition changes FA morphology in spreading HDF cells
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Figure 2. PKA inhibition changes FA morphology in spreading HDF cells.
(A) HDF cells plated on fibronectin coated glass in the absence (control) and presence of
the selective PKA inhibitor (+Rp-cAMPs) were fixed 30, 60, 90, 120 and 180 minutes after
plating and stained for paxillin. (B) Insets from cells highlighting morphological
differences between groups upon treatment with Rp-cAMPs (C) Immunofluorescence
images were analyzed at 90 minutes to determine the number of adhesions between .3 and
8 μm2 and at 120 and 180 minutes to determine FA size (D-E) and aspect ratio (F). (D)
Depicts all measured adhesion values at each timepoint. (E) Depicts all measured adhesion
values greater than 15 μm2 to highlight differences at larger adhesion area values. (F)
Depicts mean aspect ratio for all groups (n = 25 cells and n = >98 cells from 2 experiments
for # adhesions/cell and FA size, respectively; *p<.05, **** p<.0001)
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the HDFs than in the REF52 cells. At 90 minutes, both control and +Rp-cAMPs cells could
be divided into two subpopulations, cells displaying the same or very similar morphology
to the 30-minute time point and those which had spread to a larger area and no longer had
a continuous ring of adhesions around the periphery. Interestingly, of the cells no longer
showing the 30-minute phenotype, the +Rp-cAMPs cells seemed to be farther along in
adhesion separation than the control cells (Fig 2B). To quantify this difference, we
thresholded adhesions and counted those that fell between .3 and 8 µm2, a size range which
included individual adhesions but intentionally excluded larger adhesion clusters and
peripheral “adhesion ring” paxillin staining. +Rp-cAMPs cells had significantly more
individual adhesions than control cells (Fig 2C), contrary to what was observed in the
REF52 cells.
By the 120-minute timepoint, a majority of the HDFs in each treatment group were
well spread and decorated with distinct FAs. While cells in the control group had many
individual FAs, those in the +Rp-cAMPs group were observed to have more large clusters
of adhesions, although this was not statistically significant (Fig 2D and 2E). This was
surprising given the somewhat contradictory differences we observed in FA morphology
at the 90-minute timepoint in this cell line. However, it is worth noting that when measuring
individual adhesions at the 90-minute timepoint we intentionally excluded larger adhesion
clusters in both treatment groups and that these adhesion clusters were present in some
+Rp-cAMPs cells at this earlier timepoint (Fig 2B). Interestingly, cells treated with +RpcAMPs and fixed at 120 minutes had adhesions with significantly larger aspect ratios than
control cells (Fig 2 F). At 180 minutes, both control and Rp-cAMPs cells had much longer
adhesions than those observed at earlier timepoints. While there was no difference in aspect
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ratio between the two groups at this timepoint (Fig 2F), cells treated with Rp-cAMPs had
significantly larger adhesions than control cells (Fig 2D and 2E). Although there was
considerable variability within each group, PKA inhibition in HDFs did result in changes
in FA morphology. Specifically, we observed increased adhesion number at 90 minutes,
larger adhesion aspect ratio at 120 minutes, and increased adhesion area at 180 minutes in
HDFs treated with Rp-cAMP compared to control cells.
Given the differences in these cell lines, it is not surprising that overall cell and FA
morphology progress differently in spreading REF52 and HDF cells. Despite these gross
differences, we observed significant increases in FA size and aspect ratio upon PKA
inhibition in both cell lines. Although variable, these data strongly implicate a role for PKA
activity in regulation of FA dynamics in spreading cells.
3.2 Inhibition of PKA increases max and mean traction forces in spreading cells
As the physical connection between the contractile cytoskeleton and the ECM, FAs
play an integral role in cellular force transmission, and changes in FA morphology are
correlated with alterations in traction force (Balaban et al., 2001). Because of this
connection, we wondered whether the FA morphology we observed when we inhibit PKA
in spreading cells was accompanied by a change in cellular force transmission. To this end,
we used traction force microscopy to assess changes in traction force upon PKA inhibition
in spreading REF52 cells. This technique (described in detail previously (McKenzie et al.,
2018, 2020; Svec et al., 2019)) utilizes fibronectin-coated, fluorescent nanospherefunctionalized hydrogels to track changes in force exerted by cells. Fluorescent nanosphere
fields are captured during cell spreading and compared to the same field after the cells are
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Figure 3: Traction force kinetics in spreading REF52 cells during PKA inhibition
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Figure 3: Traction force kinetics in spreading REF52 cells during PKA inhibition.
(A) Traction force maps for REF52 cells plated on FN-coated, fluorescent nanospherefunctionalized hydrogels were generated using Particle Image Velocimetry (PIV) and
Fourier-Transform Traction Cytometry (FTTC) plugins for ImageJ. Traction force maps
with cell outline obtained from phase contrast images for representative cells in the absence
(control) and presence of PKA inhibitor (+Rp-cAMPs) 30, 60, 90, 120, 150 and 180
minutes after plating. (B) Max traction force was measured at each timepoint. (C) Mean
traction force was measured at each timepoint. (30, 60 min: n = 27 cells from 2
experiments, 90-180 min; n = 13 cells; *p<.05 **p<.01, using Mann Whitney test)
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lysed. Two ImageJ plugins, Particle Image Velocimetry (PIV) and Fourier Transform
Traction Cytometry (FTTC) allow us to track bead displacement between the two fields
and use the elastic modulus of the gel to calculate the force exerted by the cell.
To analyze traction forces in spreading cells, we plated REF52 cells on 125 kPa
hydrogels in the absence (control) and presence of the PKA inhibitor (+Rp-cAMPs) and
imaged them beginning 30 minutes after plating. Fluorescent-nanosphere and phase
contrast images were acquired every 30 minutes for 2.5 hours in order to track changes in
traction force magnitude and kinetics in spreading cells over a similar time period that we
observed morphological changes in FAs (Fig 3A). Cells in both control and PKA inhibited
groups showed an overall increase in max and mean traction force over the course of the
imaging period (Fig 3B and 3C). At 30 minutes, control and +Rp-cAMPs cells had
comparable max traction forces, but the control cells showed significantly higher mean
forces. At 60 minutes, +Rp-cAMPs cells had significantly higher max and mean traction
forces than control cells. While max traction force did not differ for the remainder of the
imaging period, +Rp-cAMPs cells had significantly higher mean forces at 90 and 120
minutes. Following this timepoint, traction forces in treated and control cells were not
significantly different. These data demonstrate a role for PKA activity in regulation of
cellular traction forces early in cell spreading.
3.3 Inhibition of RhoA phosphorylation on Ser188 increases max traction force at 60
minutes in spreading cells
The finding that PKA inhibition increases cellular traction forces during cell
spreading prompted us to speculate whether these changes might be due to the interaction
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Figure 4: Traction force kinetics in spreading REF52 cells expressing RhoA
and S188A.

Figure 5: PKA inhibition changes FA morphology in empty vector and RhoA, but not S188A expressing
REF52 cellsFigure 4: Traction force kinetics in spreading REF52 cells expressing

RhoA and S188A.
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Figure 4. Traction force kinetics in spreading REF52 cells expressing RhoA and
S188A
(A) Traction force maps for REF52 cells plated on FN-coated, fluorescent nanospherefunctionalized hydrogels were generated using PIV and FTTC plugins for ImageJ. Traction
force maps with cell outline obtained from phase contrast images for representative cells
expressing wild-type (RhoA) or mutant (S188A) 30, 60, 90, 120, 150 and 180 minutes after
plating. (B) Max traction force was measured at each timepoint. (n = 16 cells; *p<.05, using
Mann Whitney test)
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between PKA and RhoA, a small GTPase that serves as a master regulator of acto-myosin
contractility and contributes to cellular traction force generation. PKA phosphorylation of
RhoA on Ser188 is known to increase the interaction between RhoA and RhoGDI, resulting
in decreased RhoA activity at the cell membrane (Ellerbroek et al., 2003; Lang et al., 1996).
Thus, it is conceivable that inhibition of PKA activity might result in decreased PKA
phosphorylation of RhoA and increased RhoA activity, leading to higher traction forces.
While PKA phosphorylation of RhoA is well documented, to our knowledge there has been
no direct investigation of the effects of this modification on traction forces in spreading
cells.
To investigate this, we obtained both wild type RhoA and a mutant form of RhoA
that cannot be phosphorylated by PKA (S188A) (Ellerbroek et al., 2003). These constructs
were transiently expressed in REF52 cells, plated on traction force gels described
previously and monitored for traction forces for 2.5 hours beginning 30 minutes after
plating (Fig 4A). Since RhoA plays such an integral role in cellular contractility it was not
surprising that cells expressing either wild type RhoA or S188A had higher overall traction
forces than untransfected cells. For example, the average max traction force in
untransfected cells at 60 min was 210 Pa while cells transfected with RhoA WT at 60 min
had an average max traction force of 475 Pa. While there were not differences at any time
in mean traction force or max traction force at 30, 90, 120, 150 or 180 minutes after plating,
we did observe significantly higher traction forces in S188A cells at 60 minutes when
compared with wild type RhoA (Fig 4B and 4C). This difference is notable since it mirrors
the higher traction force we observed upon PKA inhibition in untransfected cells at 60
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minutes (Fig 3B). These data suggest that differences in traction force observed upon PKA
inhibition may be a result of decreased phosphorylation of RhoA on Ser188 by PKA.
3.4 PKA inhibition changes FA morphology in empty vector and RhoA, but not
S188A expressing REF52 cells
Since the data above show that a phosphoresistant form of RhoA to some degree
phenocopies the increase in max traction force seen upon treatment with the PKA inhibitor,
Rp-cAMPs, we wondered whether this interaction might also account for the changes in
FA morphology observed upon treatment with this inhibitor. As mentioned before, RhoA
plays an important role in assembly of stress fibers and generation of cellular traction force
(Chrzanowska-Wodnicka & Burridge, 1996). These forces are important in FA maturation,
and cells that overexpress RhoA have larger adhesion structures (Chrzanowska-Wodnicka
& Burridge, 1996; Ridley & Hall, 1992). Thus, we reasoned that PKA inhibition and the
resulting decrease in negative regulation of RhoA activity might lead to the larger adhesion
structures that we observed previously.
To investigate this, we expressed either wild type RhoA, S188A mutant RhoA, or
an empty vector control (pcDNA3.1) in REF52 cells and plated them on fibronectin-coated
glass coverslips in the absence (control) or presence of the selective PKA inhibitor, RpcAMPs. The cells were allowed to adhere for 90 minutes (a time point at which we
previously observed robust changes in FA morphology in this cell line) and the cells were
fixed and stained for paxillin (Fig. 5A and 5B). We first compared adhesion size in empty
vector control, RhoA, and S188A cells (Fig 5C). As expected, both RhoA and S188A cells
had significantly greater adhesion size than empty vector control cells. Further, S188A
cells had larger FA area than RhoA cells. When we compared aspect ratio in these cells,
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Figure 5: PKA inhibition changes FA morphology in empty vector and RhoA,
but not S188A expressing REF52 cells
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Figure 6: PKA inhibition after plating does not alter FA morphology in
REF52 cellsFigure 5: PKA inhibition changes FA morphology in empty vector
and RhoA, but not S188A expressing REF52 cells

Figure 5. PKA inhibition changes FA morphology in empty vector and RhoA, but not
S188A expressing REF52 cells.
(A) REF52 cells transiently expressing empty vector pcDNA3.1, wild type RhoA, or
S188A mutant RhoA in the absence (control) and presence of PKA inhibitor (+Rp-cAMPs)
were fixed and stained for paxillin 90 minutes after plating. (B) Insets from cells
highlighting morphological differences between groups (C-E) Immunofluorescence
images were analyzed for FA size and aspect ratio. (n = >75 cells; *p<.05, ***p<.001,
****p<.0001 using Mann-Whitney Test or Ordinary one-way ANOVA)
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while there was no difference between empty vector or RhoA cells, the S188A cells had
adhesions with significantly larger aspect ratios than empty vector and RhoA cells. We
then compared the change in both adhesion area and aspect ratio in each group upon
addition of Rp-cAMPs (Fig 5D). PKA inhibition resulted in a significant increase in
adhesion size and aspect ratio in empty vector cells. While there was no difference in
adhesion size after PKA inhibition in RhoA cells, there was a significant increase in aspect
ratio. Interestingly, there was no significant change in either adhesion area or aspect ratio
in cells expressing the S188A mutant during PKA inhibition. We further compared the
differences in adhesion area and aspect ratio between the cells treated with Rp-cAMPs (Fig
5E). We again observed that expression of either RhoA or S188A lead to a significant
increase in adhesion area over empty vector cells. Surprisingly, there was still a significant
increase in adhesion area in S188A cells when compared with RhoA. However, treatment
with Rp-cAMPs abolished any difference in aspect ratio between the three groups.
Expression of RhoA and S188A increased FA size over empty vector control cells,
while S188A alone resulted in a change in adhesion aspect ratio. PKA inhibition in these
cells altered FA morphology in empty vector control and RhoA expressing cells, but not
those expressing the phosphoresistant form of RhoA (S188A). Further, PKA inhibition
abolished any differences in aspect ratio between empty vector, RhoA and S188A cells.
This finding suggests that the changes in FA morphology, particularly aspect ratio,
observed upon inhibition of PKA activity may be due to decreased negative regulation of
RhoA by PKA.
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3.5 PKA inhibition after plating does not alter FA morphology in REF52 cells
Since we observed changes in FA morphology when we inhibit PKA in spreading cells,
we wondered whether this effect was specific to events happening early in cell spreading,
or if PKA inhibition could alter FA morphology in cells that had already been plated. To
investigate this, we plated REF52 cells on fibronectin coated glass for 90 minutes. After
30 minutes, a time at which we previously observed REF52 cells firmly attached and
beginning to develop adhesions and spread (Fig 1A), we added either vehicle control or
Rp-cAMPs to the media and incubated the cells for 60 minutes. The cells were then fixed
and stained for paxillin (Fig 6A and 6B). We did not observe differences in FA morphology
or aspect ratio in cells treated with Rp-cAMPs when compared with control cells (Fig 6C).
The lack of overt morphological differences between these two groups suggests that the
changes we observed previously upon PKA inhibition in spreading REF52 cells are
dependent upon the presence of the drug during the entirety of the 90-minute time period
that the cells were plated for.
3.6 PKA Inhibition prevents FA disassembly by microtubule regrowth
Although we routinely observed changes in FA morphology when we inhibit PKA
for the duration of cell spreading, since these cells are fixed it is difficult to pinpoint what
change in FA dynamics are leading to these morphological changes. In newly spreading,
attached, and migrating cells, FA dynamics such as adhesion growth, maturation and
disassembly take place within the same system and at the same time. Using our model of
spreading cells, it is impossible to separate dynamic FA processes to assess how PKA
inhibition changes FA morphology.
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In order to address this, we employed the drug nocodazole, a tool which uniquely
permits the separation of adhesion growth and disassembly. As discussed previously,
addition of nocodazole results in microtubule depolymerization and the subsequent and
simultaneous growth of FAs in all treated cells. When the drug is washed out, microtubules
regrow which results in simultaneous FA disassembly. Using this experimental strategy,
REF52 cells were plated on fibronectin coated glass coverslips in the absence (control) or
presence of the PKA inhibitor, Rp-cAMPs. The cells were either left untreated, incubated
with 10 mM nocodazole for 2 hours, or incubated with 10 mM nocodazole for 2 hours after
which the nocodazole treatment was washed out and the microtubules allowed to regrow
for 20 minutes. The cells were then fixed and stained for paxillin (Fig 7A). Both untreated
control and Rp-cAMPs cells had comparable adhesions. Incubation with nocodazole
resulted in adhesion growth in both control and Rp-cAMPs when compared with untreated
cells. Following nocodazole washout, while control cells had few if any remaining FAs,
the cells treated with Rp-cAMPs had seemingly unchanged robust adhesion structures. This
finding indicates that inhibition of PKA with Rp-cAMPs results in decreased FA
disassembly during microtubule regrowth.
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Figure 6: PKA inhibition after plating does not alter FA morphology in
REF52 cells

Figure 7: PKA inhibition prevents FA disassembly by microtubule
regrowthFigure 6: PKA inhibition after plating does not alter FA morphology
in REF52 cells
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Figure 6. PKA inhibition after plating does not alter FA morphology in REF52 cells.
(A) REF52 cells plated on fibronectin coated glass for 90 minutes (control) or 90 minutes
with the addition of PKA inhibitor (+Rp-cAMPs) after 30 minutes were fixed and stained
for paxillin. (B) Insets from representative cells highlighting similar adhesion morphology.
(C-D) Immunofluorescence images were analyzed for FA size (C) and aspect ratio (D).
(C) Depicts all measured adhesion values at each timepoint. (D) Depicts mean aspect ratio
for all groups (n = 43 cells; “ns” = not significant, p >.05 using Mann Whitney test)
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Figure 7: PKA inhibition prevents FA disassembly by microtubule regrowth

Figure 8: Optogenetic Localization of A-Kinase to Focal Adhesions
(OLAF)Figure 7: PKA inhibition prevents FA disassembly by microtubule
regrowth
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Figure 7. PKA inhibition prevents FA disassembly by microtubule regrowth.
(A) REF52 cells plated on FN coated glass in the absence (control) or presence of PKA
inhibitor (+Rp-cAMPs) were left untreated or were incubated with nocodazole for 2 hours
(+ nocodazole). Nocodazole was washed out and microtubules were allowed to regrow
(washout). Cells were then fixed and stained for paxillin.
Experiment was conceived by A. Senatore and A. Howe and performed by A. Howe
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3.7 Optogenetic Localization of A-Kinase to Focal Adhesions (OLAF)
The data presented above utilize pharmacological PKA inhibition to investigate
how changing total cellular PKA activity affects FAs. These data demonstrate a role for
PKA in modulating FA and traction force dynamics in spreading cells, possibly through
negative regulation of RhoA activity. They further suggest PKA may play a role in FA
disassembly. However, global inhibition of PKA activity that results from treatment with
Rp-cAMPs does not allow us to draw conclusions about where PKA is acting to have these
effects. Since we are interested in characterizing if and how PKA acts within FAs, we
developed a more targeted approach. In order to directly assess how PKA activity within
FAs affects adhesion dynamics, our lab developed “OLAF”, an optogenetic toolset which
allows for discrete recruitment of the C subunit of PKA to FAs. These optogenetic
constructs utilize OptoPKAW196R/Y204A (O’Banion et al., 2018) and have been adapted
for use in our lab. This system relies on the photodimerization interaction between
cryptochrome2 (Cry2) and the CIB protein which occurs transiently upon illumination by
470 l. OptoPKAW196R/Y204A is a mutated form of constitutively active PKA with
reduced catalytic activity that is attached to the Cry2 protein and fluorescently tagged with
mEmerald (“OptoPKAg”). The CIB protein is fused to the FA targeting protein paxillin
and tagged with mCherry so that FA dynamics can be monitored independently of construct
localization (pCIBN-mCh-Paxillin). When these constructs are co-expressed, OptoPKAg
is transiently recruited to FAs upon illumination with 470 l and changes in FA dynamics
monitored via pCIBN-mCh-Paxillin.
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Figure 8: Optogenetic Localization of A-Kinase to Focal Adhesions (OLAF)
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Figure 8. Optogenetic Localization of A-kinase to Focal Adhesions (OLAF)
(A) OptoPKAg localization before (control) and after (activation) stimulation with 470 l
every 5 seconds for 1 minute. (B) Temporal color code-generated images of pCIBN-mChpaxillin (control) or pCIBN-mCh-paxillin during 470 l stimulation (activation; every 5
seconds) captured every 30 seconds for 15 minutes. Scale bar denotes color coding. (C)
Line scan analyses of FAs undergoing assembly during control (pCIBN-mCh-paxillin;
every 30 seconds for 45 minutes) and activation (pCIBN-mCh-paxillin, 15 minutes;
pCIBN-mCh-paxillin, 15 minutes + 470 l every 5 seconds; pCIBN-mCh-paxillin, 15
minutes). Blue line on graph denotes 15-minute time period during which 470 l stimulation
took place every 5 seconds for the activation group. (D) Line scan analyses of FAs
undergoing disassembly during control (pCIBN-mCh-paxillin; every 30 seconds for 45
minutes) and activation (pCIBN-mCh-paxillin, 15 minutes; pCIBN-mCh-paxillin, 15
minutes + 470 l every 5 seconds; pCIBN-mCh-paxillin, 15 minutes). Blue line on graph
denotes 15-minute time period during which 470 l stimulation took place every 5 seconds
for the activation group.
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REF52 cells transiently expressing OLAF constructs were plated on fibronectincoated glass bottom imaging dishes and allowed to adhere for 4 hours prior to imaging. To
verify that constructs were working as intended, we first tracked localization of OptoPKAg
by briefly imaging transfected cells with 470 l and then repeatedly stimulating localization
of the construct with 470 l every 5 seconds, promoting sustained interaction between the
two constructs. Initially, OptoPKAg was observed as diffuse signal throughout the cell (Fig
8A). Upon repeated stimulation by 470 l, the construct robustly localized to paxillin
positive FAs, showing peak localization at 60 seconds (Fig 8A).
After verifying optogenetic localization of the construct to FAs, imaging was
conducted to compare FA dynamics in the presence or absence of PKA localization to FAs
with OLAF. FA dynamics were tracked over the course of three imaging periods: 1) “Preactivation” (pCIBN-mCh-Paxillin alone every 30 seconds for 15 minutes), 2) ”Activation”
(470 l stimulation every 5 seconds + pCIBN-mCh-Paxillin every 30 seconds for 15
minutes), 3) ”Washout” (pCIBN-mCh-Paxillin alone every 30 seconds for 15 minutes). As
a control, these three imaging periods were repeated without 470 l stimulation during the
“activation” period (pCIBN-mCh-Paxillin alone every 30 seconds for 3, 15-minute
periods) to compare FA dynamics without localization of OptoPKAg.
To assess whether there were differences in adhesion dynamics between activation
and control imaging periods, we used the temporal color code feature in ImageJ to generate
a temporal color-coded XY 2D image from the time series (Fig 8B). These images visualize
adhesion dynamics over the course of imaging and improve our ability to analyze
differences between the two conditions. The first frame of each time series is represented
by dark blue and subsequent frames with increasingly warmer colors as shown in the scale
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bar. We did not observe adhesion dynamics in either control or activation cells. Both
conditions showed adhesions in a variety of stages of lifetimes, with no obvious changes
upon activation.
While there were no overt differences in adhesion dynamics between the control
and activation groups when we looked at temporal color code-generated images, it is likely
that localization of PKA to FAs could affect adhesions in different stages of lifetime
differently, or perhaps only affect a specific subset of adhesions. To investigate this
possibility, we compared FAs undergoing both assembly and disassembly during control
and “activation” three-part imaging periods. Under the conditions tested, we did not
observe changes in FA assembly or disassembly (Fig 8C and 8D). However, we were able
to verify that these constructs work as intended: producing robust localization of
OptoPKAg to FAs upon 470 l stimulation. This proof of principle experiment illustrates
the utility of these constructs and provides important framework on which to build further
investigation.
3.8 Summary
PKA inhibition with the selective inhibitor Rp-cAMPs changed FA morphology in
spreading REF52 and HDF cells. This change in FA size and aspect ratio was accompanied
by an increase in max traction force 60 minutes after plating and mean force from 60-120
minutes after plating. Expression of a nonphosphorylatable mutant form of RhoA (S188A)
resulted in an increase in max traction force at 60 minutes when compared to wild type
RhoA and produced a similar FA phenotype to PKA inhibition. Thus, the difference in FA
morphology and increase in traction force during PKA inhibition may be a consequence of
a lack of negative regulation of RhoA by PKA. While no difference in adhesion
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morphology was observed when PKA inhibition took place after plating cells, there was a
marked reduction in FA disassembly during microtubule regrowth when PKA was
inhibited. Preliminary experiments using the optogenetic construct OLAF revealed robust
localization of the construct to FAs but failed to find differences in adhesion dynamics
upon this localization. The work presented above demonstrates a role for PKA activity in
the regulation of FA and traction force dynamics in spreading cells. It implicates the
involvement of PKA in FA disassembly during microtubule regrowth and validates OLAF
construct localization for further investigation.
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CHAPTER 4: Discussion
The data presented above support a role for PKA in the regulation of FAs.
Specifically, we found that PKA inhibition increases FA size, FA aspect ratio and traction
force in spreading cells. Further investigation suggested these effects were due, at least in
part, to the negative control exerted by PKA over the small GTPase, RhoA. Here,
expression of a nonphosphorylatable mutant form of RhoA (S188A) resulted in a similar
FA phenotype to PKA inhibition. Cells expressing this mutant did not exhibit changes in
FA morphology upon treatment with Rp-cAMPs, while cells expressing wild type RhoA
did show a change in aspect ratio. Further, the S188A expressing cells exhibited an increase
in max traction force when compared with control RhoA cells during the same time point
as Rp-cAMPs treated cells spreading on fibronectin. PKA inhibition during a nocodazole
washout assay, where microtubule depolymerization and polymerization were used induce
adhesion assembly and disassembly, resulted in decreased FA disassembly. Finally,
preliminary imaging with OLAF demonstrated the ability to optogenetically target active
PKA to FAs, warranting further investigation and optimization of this tool. The data
presented here demonstrate a role for PKA in controlling adhesion and traction force
dynamics in spreading cells and provide technical groundwork to further investigate how
active PKA within adhesions may affect their dynamics.
4.1 PKA controls FA morphology and traction force dynamics in spreading cells
The data presented above showed that PKA inhibition increased FA size and aspect
ratio and increased cellular traction force. Since PKA exerts negative regulation over RhoA
(Ellerbroek et al., 2003; Lang et al., 1996), and cells with high levels of RhoA activity
show larger adhesions and increased cellular tension (Chrzanowska-Wodnicka & Burridge,
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1996) we sought to determine whether this interaction was connected to our observations.
As expected, expression of either RhoA or S188A both showed significantly greater FA
size than empty vector control cells, while there was no difference in aspect ratio between
empty vector and RhoA cells. On the other hand, S188A cells had significantly larger
adhesions than RhoA expressing cells as well as significantly greater aspect ratios than
either RhoA or empty vector control cells. When we inhibited PKA in these cells,
expression of either RhoA or S188A still resulted in significantly larger adhesion area than
empty vector cells. A difference in adhesion size persisted between S188A and RhoA
treated with Rp-cAMPs, which was unexpected given that we hypothesized PKA inhibition
would eliminate the difference in adhesion size between these two groups. Interestingly,
inhibiting PKA in S188A cells had no effect on FA aspect ratio while it increased FA aspect
ratios in RhoA wild type cells and empty vector control cells. Thus, the increase in FA
aspect ratio that we observe when we inhibit PKA seems to be related to the
phosphorylation of RhoA by PKA.
When we expressed these constructs and looked at cellular traction force, we
observed a significant different in max force at 60 minutes, similar to the difference in max
force in control and +Rp-cAMPs cells. However, we failed to see significant differences in
mean force in these cells compared to those seen in control and +Rp-cAMPs cells. Given
this result, it is possible that the increase in mean traction force observed in +Rp-cAMPs
cells is not due to loss of PKA-mediated phosphorylation of RhoA. However, this seems
unlikely given the central role of RhoA in the generation of traction force. Further, it is
noteworthy that at each time point, the average max and mean force of the S188A cells is
higher than the RhoA expressing cells. Since cells expressing either wild type RhoA or
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S188A RhoA on average exert much higher forces than the control cells (see the difference
in scale bars for traction force maps in Fig 3 vs Fig 4), it is possible that these higher forces
narrow the force difference between the two groups. Considering the low number of cells
sampled here, it is worth repeating this experiment to determine whether the difference in
mean force between these groups reaches statistical significance upon increasing the
number of cells analyzed. It may also be advantageous to titrate down the amount of DNA
used to transfect the cells which could decrease the effect of RhoA overexpression on
traction force, possibly unmasking important differences.
Since expression of nonphosphorylatable RhoA (S188A) mirrored changes in FA
morphology and traction force in spreading cells, it seems that phosphorylation of RhoA
by PKA likely plays a role in modulating these processes. However, these experiments
were limited in that we only examined FA morphology and traction force in wild type
RhoA and the S188A mutant, which prevents phosphorylation of RhoA by PKA.
Comparing wild type, S188A and S188E RhoA (which mimics the PKA-phosphorylated
state of RhoA) (Ellerbroek et al., 2003) could expand our understanding of how PKA
phosphorylation of RhoA affects FAs and traction forces. Further, assessing RhoA activity
during PKA inhibition in spreading cells through either biochemical methods or with a
FRET-based RhoA biosensor (Yoshizaki et al., 2003) will allow us to more definitely
connect PKA-mediated changes in RhoA activity to the differences we observed in FA
morphology and traction force.
Despite the limitations described above, these observations broaden our
understanding of the consequences of phosphorylation of RhoA by PKA. The importance
of this interaction has previously been demonstrated in the control of a protrusion71

retraction cycle at the leading edge of migrating cells and in protecting RhoA from
ubiquitin-mediated proteasomal degradation (Rolli-Derkinderen et al., 2005; Tkachenko et
al., 2011). However, the data presented above (to our knowledge) is the first report to
functionally connect the phosphorylation of RhoA by PKA to FA morphology and traction
force.
If inhibition of PKA does indeed alter FA morphology and traction force through
RhoA, discerning the pathway through which this occurs will be valuable to the
understanding of the role of tension in controlling FA dynamics. As briefly mentioned
earlier, as adhesions mature, they grow in both size and length as their composition
changes. In addition, as adhesions mature they are exposed to increased force upon
reinforcement of their association with contractile acto-myosin stress fibers. Thus, our
observations that PKA inhibition increases FA size (adhesion area) and length (aspect
ratio) invite the idea that PKA inhibition is altering adhesion maturity in some way.
Indeed, previous studies have shown the importance of RhoA mediated cellular
tension in the growth and maturation of FAs (Chrzanowska-Wodnicka & Burridge, 1996;
Kuo et al., 2011; Nobes & Hall, 1995). A noteworthy recent paper by Young and Higgs
(2018) reveals an interesting aspect of FA maturation whereby FAs evolve through the
splitting of laterally associated units which then elongate to form mature adhesions (Young
& Higgs, 2018). Interestingly, this “FA splitting” required VASP, a known PKA substrate,
and was accompanied by an increase in tension (Young & Higgs, 2018). Conceivably, this
“FA splitting” could represent a maturation process that is disrupted during PKA inhibition
and results in the larger and longer adhesions which we observed. While this paper did not
investigate the role of RhoA in “FA splitting”, it is not unlikely that the increase in tension
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they observe during splitting events may be connected to tension downstream of RhoA
activity. In addition to this possibility, it is well appreciated that acto-myosin contractility
recruits FA proteins to strengthen the connection between integrin and the cytoskeleton
and promote FA maturation (Del Rio et al., 2009; Kuo et al., 2011; Pasapera, Schneider,
Rericha, Schlaepfer, & Waterman, 2010). Thus, increasing RhoA activity following PKA
inhibition could result in increased tension on FAs (reflected by an increase in traction
force), leading to recruitment of tension sensitive FA components.
Characterizing the molecular makeup of adhesions in cells treated with a PKA
inhibitor may reveal if and how their composition differs from control cells. The
immunofluorescence data presented here used only paxillin as a marker for FAs. While
paxillin is commonly used to visualize adhesions, comparing different adhesion proteins
which localize to FAs at different stages of their lifetime, such as zyxin or tensin, would
likely inform our understanding of how the composition of adhesions is affected by PKA
inhibition. It would also be interesting to know if PKA inhibition affects the cellular
distribution and balance between different types of integrins, which have previously been
shown to differentially regulate adhesion size, traction force, and GTPase activity (Costa,
Scales, Ivaska, & Parsons, 2013; Danen, Sonneveld, Brakebusch, Fässler, & Sonnenberg,
2002; Schiller et al., 2013). Differences in molecular composition could provide further
insight into how PKA activity affects the recruitment of different adhesion proteins and
regulates FA maturation.
The idea that PKA inhibition increases cellular tension via RhoA to increase FA
size is consistent with the observation that increased traction force (60 minutes) precedes
our observation of altered FA morphology (90 minutes). However, it is worth noting that
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our observations of both FA morphology and traction force took place only every 30
minutes. It is possible that FA differences emerge earlier than 90 minutes, perhaps
following increases in traction force more closely. In this case, increasing the time
resolution during the 60 to 90-minute time gap could be informative. It is also possible that
differences in FA morphology exist at 60 minutes, but our microscope lacks the resolution
to capture them. Thus, increasing spatial resolution and decreasing noise by using higher
magnification imaging, TIRF (Total Internal Reflection Fluorescence microscopy), or
super resolution microscopy could help to resolve these differences.
In fact, several lines of evidence suggest that the paradigm of increased tension
leading to larger adhesions is oversimplified. Recent studies using optogenetic tools to
control RhoA activity showed an increase in cellular tension and stress fiber assembly upon
RhoA activation but failed to observe an alteration in FA size or distribution (Oakes et al.,
2017; Valon, Marín-Llauradó, Wyatt, Charras, & Trepat, 2017). Interestingly, it seems that
adhesion size is correlated with traction force only at the initial stages of adhesion assembly
and growth (Stricker, Aratyn-Schaus, Oakes, & Gardel, 2011). In fact, Stricker et al.
(2011) showed that mature adhesions had no correlation between size and traction force
and were able to withstand large increases in force with no increase in size. This may
explain why we observed differences in traction force earlier than FA morphology
differences—the increase in cellular tension was required during adhesion assembly to alter
FA morphology.
This idea also provides an intriguing explanation for why we failed to observe
differences in FA morphology in cells that were already plated. It is possible that there
was insufficient time between the addition of Rp-cAMPs and cell fixation. In this case, the
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increased cellular tension following PKA inhibition may not have occurred during the
assembly phase of enough adhesions to have an appreciable effect on overall FA
morphology. Repeating this experiment using a longer Rp-cAMPs incubation time may
lead to observable changes in FA morphology. However, it is important to consider that a
much greater proportion of the adhesions during the initial stages of cell spreading are
undergoing assembly when compared to adhesions in cells that are already plated. Thus, it
is likely that FA morphological differences resulting from PKA inhibition in pre-plated
cells may take much longer to emerge, and perhaps never be as striking as when PKA is
inhibited during cell spreading.
Another factor to consider when comparing spreading and pre-plated cells relates
to previous work showing that PKA activity is modulated by cell adhesion and during cell
spreading (Howe et al., 2002). Interestingly, the time scale over which PKA activity
increases during cell spreading (Howe et al., 2002) corresponds with significant increases
in max traction force that we observed when we inhibit PKA or express S188A RhoA. This
change in PKA activity could play a significant role in modulating RhoA activity during
this time course and may be important in allowing for efficient FA turnover and cell
spreading. Thus, spreading cells may be more sensitive to the effects of PKA inhibition on
FA morphology because of both the importance of PKA activation during this time frame
and the increased adhesion assembly that is taking place.
Taken together, these data suggest that PKA may control RhoA activity and
influence FA morphology via increased tension during adhesion assembly. However, it is
worth noting that the idea of tension-mediated FA maturation has been challenged (Lawson
& Burridge, 2014). This is supported by the observations that a) FA maturation occurs even
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when myosin II-generated cellular tension is significantly reduced and b) tension alone is
not sufficient to drive maturation (Oakes et al., 2012). While some degree of myosin II
activity is needed to prevent full disassembly of adhesions, adhesion size is insensitive to
inhibitors of contractility over a wide range (Stricker, Beckham, Davidson, & Gardel,
2013). Thus, it has been proposed that myosin II-mediated actin crosslinking, rather than
contractility itself, is the primary contributor to adhesion size and maturation downstream
of RhoA (Lawson & Burridge, 2014). This hypothesis does not preclude the possibility
that PKA inhibition increases RhoA activity which leads to increased cellular traction force
and larger adhesions. However, it does invite the possibility that these two effects might
represent distinct consequences of RhoA activity on myosin II—increased contractility and
actin crosslinking. Examining these two effects independently using mutants of myosin II
that are deficient in motor activity but retain actin crosslinking ability could help to
elucidate these mechanisms (Lombardi, Knecht, Dembo, & Lee, 2007).
4.2 PKA inhibition prevents FA disassembly by microtubule regrowth
While either tension or actin crosslinking-mediated FA maturation could produce
differences in FA morphology observed upon PKA inhibition, results from the nocodazole
washout experiment suggest that PKA inhibition might interfere with FA disassembly.
Given that PKA inhibition decreased FA disassembly during microtubule regrowth, it is
possible that this change in FA dynamics is what is leading to morphological differences
in FAs when we inhibit PKA or express S188A RhoA in spreading cells.
In fact, there is evidence connecting both PKA and RhoA signaling to microtubule
dynamics. RhoA activity is modulated by microtubule disruption (Birukova, Smurova, et
al., 2004; Enomoto, 1996). Nocodazole treatment leads to increased RhoA activity,
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generally attributed to the RhoA GEF-H1 which is released from microtubules upon
depolymerization (Birukova, Smurova, et al., 2004; Chang, Nalbant, Birkenfeld, Chang, &
Bokoch, 2008; Pan et al., 2020). Of interest, a study examining the effects of cAMP (the
canonical activator of PKA) on endothelial barrier dysfunction found that elevating levels
of cAMP protected against microtubule depolymerization by nocodazole (Birukova, Liu,
Garcia, & Verin, 2004). Elevation of cAMP attenuated the increase in RhoA activity after
nocodazole treatment and was inhibited by PKI, a peptide inhibitor of PKA. This provides
evidence for the involvement of PKA in the modulation of RhoA signaling during
microtubule depolymerization. However, RhoA activity in this context has previously been
tied to FA growth and maturation during microtubule depolymerization, rather than during
regrowth and FA disassembly which we observed.
Although RhoA is traditionally involved in FA growth, tension downstream of its
activity seems to both positively and negatively contribute to FA disassembly. Myosin IImediated tension leads to an increase in recruitment of FA components (such as calpain)
that are involved in disassembly (Kuo et al., 2011). Further, RhoA signaling downstream
of RIAM is important for FA disassembly, and FA disassembly at the rear of migrating
cells requires acto-myosin generated tension (Coló et al., 2012; J. Liu et al., 2021). In that
vein, one might expect to see increased FA disassembly upon increased tension (following
increased RhoA activity), rather than decreased disassembly.
However, local relief of tension is also thought to play a role in FA disassembly,
particularly within the context of microtubules (Kaverina et al., 1999). Indeed, FAK, which
plays an important role in FA disassembly, has been shown to locally decrease RhoA
activity through activation of p190RhoGAP to decrease tension and promote FA turnover
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(Ren et al., 2000; Schober et al., 2007). The kinase Arg, which is activated following
integrin adhesion, has also been shown to inhibit RhoA through p190RhoGAP to decrease
tension and promote FA disassembly (Peacock et al., 2007). Notably, both FAK-null and
Arg-null cells show adhesion morphology that is markedly similar to PKA inhibited cells
(Peacock et al., 2007; Schober et al., 2007). Thus, it is possible that PKA-mediated
phosphorylation of RhoA serves as an additional level of regulation to allow for the release
of tension required for adhesion disassembly.
To investigate this possibility, performing nocodazole washout studies in RhoA and
S188A expressing cells may shed light on whether PKA inhibition prevents FA
disassembly through increasing RhoA activity. Given the conflicting roles of tension in FA
disassembly, it would also be interesting to examine how PKA inhibition affects intraadhesion tension, and how this correlates with changes in FA dynamics. This could be
accomplished through the use of a FRET-based FA tension sensor, such as talin tension
sensor (Kumar et al., 2016), and would provide valuable insight into whether PKA
inhibition alters FA dynamics through changes in tension.
While a role for PKA in modulating FA disassembly through RhoA activity is
interesting and plausible, it is also possible that PKA inhibition affects microtubules
directly to decrease FA disassembly during nocodazole washout. PKA has been shown to
interact with and phosphorylate a number of microtubule-associated proteins (Kelkar &
Martin, 2015; Mo, Cho, Choi, Lee, & Kim, 2019). Indeed, the microtubule associated
protein-2 (MAP2), important for microtubule stability, was among the first AKAPs
discovered (Theurkauf & Vallee, 1982). Thus, PKA inhibition may directly decrease
microtubule regrowth or stabilization upon nocodazole washout, rather than affecting FAs
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themselves. Examining the integrity of microtubules during regrowth to see if PKA
inhibition alters their structure will likely inform whether PKA inhibition affects FA
disassembly through a direct effect on microtubule structure.
Although it is possible that PKA inhibition increases RhoA activity to inhibit FA
disassembly, whether these effects are similar to those we observed in spreading cells
remains to be determined. Preliminary evidence from live cell imaging in spreading REF52
cells expressing mCherry paxillin (A. Senatore, unpublished data) supports this pattern,
although higher temporal resolution and more experiments will be required to draw
conclusions from this data. It will be valuable to expand this investigation and analyze FA
dynamics in spreading cells during both PKA inhibition and S188A RhoA expression
which will inform whether decreased FA disassembly is responsible for the morphological
differences we observed. A valuable tool in this endeavor will be the Focal Adhesion
Analysis Server (FAAS), which automatically processes time lapse images of fluorescently
labeled FA proteins and analyzes adhesion dynamics (Berginski & Gomez, 2013).
Correlation of altered adhesion dynamics with changes in cellular traction force or intraadhesion tension will increase our understanding of how force contributes to these altered
dynamics.
While the data discussed above demonstrate a role for PKA in controlling FA and
traction force dynamics, the global cellular inhibition of PKA employed makes it difficult
to discern whether these changes were due to PKA activity within adhesions themselves or
elsewhere in the cell. Indeed, traditional pharmacological and overexpression approaches
make it impossible to draw conclusions about localized activity. Given this limitation,
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investigation into the role of PKA activity specifically within FAs requires a more targeted
strategy.
4.3 Optogenetic Localization of A-kinase to Focal Adhesions (OLAF)
A major shortcoming of the work described above is the inability to specifically
target PKA activity within FAs; OLAF neatly circumvents these issues. Imaging of OLAF
constructs expressed in REF52 cells showed robust localization of active PKA to FAs. This
application of the Cry2/CIB optogenetic system represents a novel, highly controllable,
and reversible way in which to study the effects of PKA activity on FAs.
Although the limited analysis presented here did not uncover any obvious
differences in adhesion assembly or disassembly, this does not by any means preclude the
possibility of finding differences. The power of this tool to investigate how PKA activity
affects FAs is complicated by the inherent complexity of adhesions themselves. Thus, it
will likely require highly sophisticated and thorough analyses which are beyond the scope
of this project. Within one cell, there are different types of adhesions which may all be
affected by PKA activity in different ways, or possibly only FAs within specific regions of
the cell (such as the lamellipodia or trailing edge) are affected. Further, many of these
adhesions are at different stages of their lifetime—undergoing assembly, maturation, and
disassembly at different times over the course of activation, which considerably
complicates our analysis. This effort will also benefit from the use of the FAAS mentioned
above and will require the imaging of many cells during both activation and control time
periods.
If, following these thorough analyses we still fail to observe differences in adhesion
dynamics during PKA localization it would still not necessarily mean PKA does not play
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a role here. Rather, it may be that there are underlying technical reasons for the lack of an
observed effect. For example, optimization of the imaging protocol employed, including
varying the time period of activation or the length and strength of light used to induce
localization may have profound effects. Another possibility is that using paxillin as a
targeting construct does not place active PKA in an ideal position to phosphorylate target
proteins. Using a different adhesion protein which is located within a different region of
adhesions could yield different results. Additionally, adding a longer linker within the
construct would allow for a greater area in which active PKA could interact with target
proteins. Despite these technical hurdles, the data shown here underscore the potential
OLAF has as a powerful tool to study the effect of PKA on FAs.
4.4 Conclusions and Future Directions
The work presented here implicates a role for PKA in controlling FA dynamics and
traction forces in spreading cells, possibly through effects on RhoA. While we also
observed inhibition of FA disassembly, it is unknown whether these differences were
similar to those we saw in spreading cells or the result of a distinct effect of PKA inhibition
on microtubules. Further work is needed to definitively identify the mechanisms by which
PKA affects FA morphology and how alterations in adhesion dynamics lead to these
changes. Our lab remains interested in studying localized PKA signaling, and promising
unpublished data from our lab suggests PKA is indeed anchored within FAs. Investigating
the consequences of this anchoring on PKA substrates and overall adhesion dynamics will
provide additional context with which to frame the observations presented above.
In summary, the work presented in this thesis provides evidence for PKA in
controlling FA morphology and cellular traction force and suggests PKA may also regulate
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FA disassembly. Further, we present preliminary data introducing an optogenetic construct
that can localize active PKA to FAs and will be an invaluable tool with which to study the
consequences of PKA activity on FAs. These findings contribute to the growing body of
literature that highlights the role of PKA in adhesive and mechanically regulated signaling
and provides a framework on which to build further investigation into these signaling
networks.
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